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Abstract 
The MuSK system is important in the development and maintenance of the neuromuscular 
junction.  The neuromuscular junction is a chemical synapse that is important in muscle 
contraction. Research has shown that aged NMJ experience structural impairments, resulting 
in decreased efficiency of synaptic transmission and subsequent muscle contraction.  Previous 
studies concerning reduced gene dosage of proteins of the MuSK system focused on 
homozygous knockouts. However, the prenatal death of the null mice prevented study of the 
role of the MuSK system in aged mice. Here, I studied the influence of the MuSK system in 
aged mice, by comparing mice with reduced gene dosage of agrin and rapsyn from the MuSK 
system. In addition, I studied the influence of elevated MuSK expression. I hypothesised that 
reduced gene dosage of agrin and rapsyn (major proteins of the MuSK system) may exacerbate 
and/or prematurely reveal age associated changes of the NMJ. On the other hand, I predicted 
that elevated MuSK expression would delay and/or prevent age associated changes at the 
NMJ. With the use of fluorescence confocal microscopy and immunohistochemical techniques 
I quantified and analysed pre-synaptic and post-synaptic structural integrity of the NMJ in wild 
type controls and affected groups.  
The experimental results do not seem to lend evidence to my hypotheses. They suggest that 
reduced rapsyn or agrin dosage have no effect on the structural integrity of the neuromuscular 
junction. Similar neuromuscular junction integrity was also noted in MuSK elevated samples, 
suggesting increased MuSK dosage has no effect.  
The L25 transgenic line is generated by the random insertion of the growth promoter sef gene. 
A subset of the offspring from L25+/- and L25+/- mating developed motor symptoms 
reminiscent of mouse models of motor neuron disease (most likely due to the disruption of an 
endogenous gene). The affected L25 mice were recently found to displayed hind limb 
iv 
 
spasticity, body tremor and paralysis (Eva Kitchkin, Honours Thesis 2014). Here, using the same 
techniques as in the study of the MuSK system, I investigate whether symptoms from the L25 
mice line involve changes in motor endplate innervation, which would imply the involvement 
of lower motor neurons.  
The results from this study suggests that the nerve terminals, as well as lower motor neurons, 
are not involved in the affected L25 animals.  
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 Chapter one: Introduction. 
The Mammalian Neuromuscular 
Junction 
 
 
 
 
 
 
1.1 Structure of the Neuromuscular Junction 
Each skeletal muscle is controlled by a group of motor neurons, termed a motor pool. The 
number of muscle fibres connected by one motor neuron is a motor unit. Therefore, each 
muscle is composed of many motor units. The neuromuscular junction (NMJ) is a chemical 
synapse that is located between a motor neuron and skeletal muscle fibre with highly 
specialised sub-cellular components (Roder et al., 2010; Wu, Xiong, & Mei, 2010). Each muscle 
fibre is innervated at a single site, called the motor endplate, by a myelinated motor axon. 
Major components of the NMJ include: the motor nerve terminal with its pre-synaptic 
membrane, the synaptic space (cleft), a terminal Schwann cell and the postsynaptic membrane 
which is lined with acetylcholine receptors (Arrowsmith, 2007; Liang & Han, 2013)).  The nerve 
terminal is highly specialised to release the neurotransmitter, acetylcholine (Ach). Large 
numbers of ACh secreting synaptic vesicles, mitochondria and filamentous proteins are located 
within the nerve terminal (Sanes & Lichtman, 1999).  The postsynaptic membrane contains 
junctional folds. Acetylcholine receptors (AChR) are present at high density at the crest of 
these folds. This results in the NMJ resembling a pretzel shape in rodents. In humans and 
chickens it is grape-like shaped and branched in frogs. (Sanes & Lichtman, 2001; Wood & 
Slater, 2001).  
 
Each skeletal muscle fibre is innervated by a motor neuron. An axon is sent via a plexus of 
nerves to a target muscle. Here, it loses its myelin sheath and branches out in “a fine spray” or 
terminal endings, innervating individual muscle fibres. The nerve terminals that lies directly 
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above each motor endplate contain synaptic vesicles that are 50nm in diameter. The synaptic 
vesicles contain the neurotransmitter Ach, which is essential for synaptic transmission.  
Schwann cells at the NMJ cap the nerve terminals. This provides support and protection from 
mechanical and chemical injury. These terminal Schwann cells also phagocytose nerve 
terminals if the nerve is damaged. They also have a role in nerve terminal remodelling. 
Schwann cells are involved in the modulation of synaptic activity by increasing cytosolic 
calcium concentration in response to neurotransmission (neurotransmitter release) (Auld et 
al., 2003) 
Many active zones are present in the presynaptic membrane that immediately overlays the 
AChRs. These active zones are thickened portions of the presynaptic membrane to which 
synaptic vesicles dock, facilitating regulated fusion with the membrane, to release the 
neurotransmitter ACh. The collapse of proteins associated with synaptic vesicle docking, fusion 
and release results in the appearance of a ‘thickened membrane’. The active zones are present 
in an ordered arrangement with synaptic vesicles clustering above each active zone. Exocytosis 
of synaptic vesicles and release of ACh occurs at active zones during neuromuscular 
transmission (Fig 1.1) (Hall & Sanes, 1993; Heuser & Reese, 1981; Wood & Slater, 2001).  
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Fig 1.1.1  Structure of Agrin at the NMJ.  
This figure illustrates the specialisation of the pre-synaptic nerve terminal and the post-
synaptic membrane. An action potential that is propagated down the axon terminal opens the 
voltage gated calcium channels (VGCC) at the pre-synaptic region. VGCC are N and P/Q type. It 
is dominated by P/Q type at mature endplates. Vesicle fusion occurs at the active zones, 
resulting in the release of the neurotransmitter Ach. AChRs are then activated at the post-
synaptic membrane. Influx of sodium and calcium ions leads to postsynaptic depolarisation 
and the consequent opening of voltage gated sodium channels (VGSC). An action potential is 
produced that travels down the muscle fibre leading to muscle contraction  (Ban & Phillips, 
2015)  
Chapter one: Introduction  
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1.2 Neuromuscular transmission at the NMJ 
Synaptic transmission at the NMJ is solely excitatory, resulting in muscle contraction.  
Neuromuscular transmission functions to produce a depolarising endplate potential large 
enough to initiate an action potential, triggering muscle contraction. The large endplate 
potential amplitude is ensured by the large amount of acetylcholine released per nerve 
impulse:  greater than is required to excite the muscle fibre. This is the ‘safety factor’ that 
ensures effective neuromuscular transmission even under physiological stresses (Arrowsmith, 
2007; Wood & Slater, 2001).  
 
Arrival of an action potential at the nerve terminal triggers activation of voltage-gated calcium 
channels at the active zones resulting in an increase of free calcium ions within the nerve 
terminal. This process is thought to be mediated via synaptotagmin, a calcium binding protein 
that is localised to the synaptic vesicles and is the trigger for their calcium induced exocytosis. 
The calcium interacts with the synaptic vesicles that are docked within 100nm of the active 
zones, resulting in synaptic vesicle docking at the active zones, exocytosis and subsequent 
synaptic vesicle fusion whereby the vesicles fuse with the pre-synaptic membrane of the active 
zone, releasing Ach from its vesicular stores into the synaptic cleft. The ACh rapidly diffuses 
across the synaptic cleft, where it interacts with AChRs the post-synaptic membrane. This 
interaction results in a conformational change of AChRs. The newly opened pore-like lumen of 
the channel allows the flow of sodium into the intracellular compartment of the cell (Unwin, 
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Miyazawa, Li, & Fujiyoshi, 2002). The influx of sodium and calcium ions through the AChR 
channels results in an endplate potential. This triggers the opening of voltage gated sodium 
channels in the depths of the post-junctional folds. The resulting action potential travels along 
the muscle fibre causing calcium is to be released from the sarcoplasmic reticulum and muscle 
contraction. The endplate potential is terminated when ACh dissociating from the AChR is 
degraded by acetylcholinesterase within the synaptic cleft (Chapman, 2008; Hall & Sanes, 
1993; Hughes, Kusner, & Kaminski, 2006).  
 
 
1.3 Acetylcholine receptor clustering in the postsynaptic 
membrane 
Fast and efficient synaptic transmission requires high density of closely packed AChRs within 
the post-synaptic membrane. AChRs are pentameric ligand gated cation channel complexes 
that are comprised of various subunits. Each adult AChR is comprised of two α1 subunits 
together with single β1, δ1, and ε subunits. During development and in certain other situations 
a ϒ subunit substitutes for the ε subunit, forming the foetal AChR isoform. During 
embryogenesis, prior to developing muscle cells becoming innervated, foetal AChRs are 
expressed along the full length of the muscle fibre. Innervation of these fibres results in the 
down-regulation of foetal AChR expression and its replacement by the adult AChR receptor 
which becomes localized to the postsynaptic membrane of the NMJ. The foetal switch occurs 
during polyneural innervation loss around 1-2 weeks post birth for mice. (Hughes et al., 2006). 
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1.4 The MuSK Signalling pathway 
The MuSK system consists of various signalling molecules and proteins that regulate NMJ 
development and maintenance. In particular the MuSK system is necessary during 
development for forming and stabilizing the postsynaptic AChR cluster, as is described below.  
1.4.1 Agrin 
1.4.1.1 Structure of Agrin 
               Agrin, a heparin sulphate proteoglycan, is considered to be the major organiser of post-
synaptic differentiation at the NMJ. It is a protein approximately 200 kD and contains EGF-like 
domains as well as two discrete laminin-like domains. These domains are located in the 
carboxy terminal region of agrin. Sequences located in the amino terminal region of agrin are 
thought to allow for agrin and extracellular matrix association.  
Agrin occurs in several isoforms as a result of alternative splicing (Fig 1.2). These isoforms have 
a range of AChR clustering efficiencies at the NMJ. Multiple agrin isoforms generated by 
alternative splicing have been compared for their ability to cluster AChRs. The ability to cluster 
AChRs was determined using an assay involved a truncated soluble form of agrin being 
expressed in COS cells. This C-terminal agrin fragment included the RNA splicing sites. Medium 
from the COS transfected cells containing the secreted agrin fragment were then added to 
cultured muscle cells where the number of AChR induced to form was determined. Although 
all forms of agrin were found to induce AChR clustering, the splicing form uniquely made in 
neurons (‘neural agrin’) was the most efficient, even when similar amounts of each agrin 
isoforms were produced. The form produced in skeletal muscle (‘muscle agrin’) was shown to 
be only very weakly active in clustering AChRs, when compared with neural agrin (Ferns, 
Campanelli, Hoch, Scheller, & Hall, 1993). However, there are instances where muscle agrin 
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has been shown to lack the ability to cluster AChRs at all. This was shown by studying AChR 
aggregates produced by different agrin isoforms by incubating cultured chick myotubes with 
excess agrin recombinant protein. AChR clustering activity was most potent in agrin isoforms 
released from motor neurons, while recombinant muscle agrin did not show any activity. 
These results seem to indicate that muscle agrin does not play a role in AChR clustering 
(Gesemann, Denzer, & Ruegg, 1995). 
              The murine agrin gene is known to produce two distinct isoforms that exist with different NH2 
terminal regions, known as short NH2 (SN) and long NH2 (LN) isoforms (Fig 1.2). These 
isoforms differ in subcellular localisation, tissue distribution and function. LN isoforms are 
known to be present in both neural and non-neural tissues while the motor neurons were one 
of the few tissues to express the SN isoform. LN agrin isoforms have been associated with NMJ 
formation as was shown in LN mutants, which developed drastically impaired NMJs, similar to 
full agrin mutants as described in (Gautam et al., 1996). SN isoforms may play a role in the 
development or function of central neurons (Burgess, Skarnes, & Sanes, 2000). 
1.4.1.2 Role of neural agrin at the NMJ 
 
               Agrin is synthesised by motor neurons and released by the nerve terminal into the synaptic 
cleft. When added to cell culture neural agrin triggers AChR cluster formation and in mouse 
embryos it is critical for post-synaptic differentiation (Sanes & Lichtman, 2001). Agrin activates 
a receptor tyrosine kinase called Muscle specific kinase (MuSK), forms a complex with LRP4 (an 
agrin co-receptor), to induce MuSK phosphorylation and subsequent AChR clustering in muscle 
cells {Zhang, 2008}. Several lines of evidence have shown that agrin and MuSK signalling is 
essential for formation and stability of AChR clusters. Mouse embryos lacking the agrin gene 
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were immobile and died shortly after birth due to respiratory failure. Their muscles showed 
markedly reduced numbers of AChR clusters. These mice also showed abnormal nerve 
terminals. Also, branching of the intramuscular nerve did not establish normal muscle contacts 
or correctly specialised or positioned nerve terminals (Gautam et al., 1996). A limited number 
of non-innervated AChR clusters were detected in agrin-deficient mice but much fewer than 
normal.  The role of agrin in AChR clustering and stability was also shown in a study where 
myoblasts, that were engineered to secrete an agrin fragment, were placed in regions devoid 
of nerve. Host muscle fibres were then observed to express AChR gene transcripts, similarly to 
a normal adult NMJ. Also, innervated fibres were injected intracellularly with agrin in the extra-
synaptic region. Ectopic post-synaptic structures were then observed, complete with clustering 
of AChR channels, acetylcholinesterase and accumulation of subsynaptic myonuclei (Jones et 
al., 1997). In addition, anti-agrin antibodies were shown to block neurite-induced AChR 
aggregation in myotubes (Reist, Werle, & McMahan, 1992). Also, it was shown that injecting a 
plasmid encoding neural  agrin into denervated soleus muscles of rats, resulted in muscle 
fibres forming AChR clusters reminiscent of a developed post-synaptic region of a NMJ. The 
specializations included plasma membrane infoldings, myonuclei accumulation and 
cytoplasmic protein aggregates (Cohen, Rimer, Lomo, & McMahan, 1997). This gives evidence 
for neural agrin acting as a major NMJ organiser, both in its formation and maintenance. 
 
 
 
 
 
Chapter one: Introduction  
11 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1.2 Structure of Agrin at the NMJ.  
The structure of the agrin molecule showing the laminin binding domains (L) and EGF domains 
(E). The three alternative splice sites of agrin are represented by ‘X, Y and Z’. Short and long 
terminal variants are also seen here as ‘LN and SN’. (Ngo, Noakes, & Phillips, 2007)  
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1.4.2 MuSK 
1.4.2.1 Structure of MuSK 
Muscle specific kinase (MuSK), is a 100 kDa transmembrane tyrosine kinase that is critical for 
the development and maintenance of the mammalian NMJ. The MuSK ectodomain contains 
four globular domains; three N-terminal immunoglobulin-like (Ig) domains and a cysteine rich 
c-terminal (Stiegler, Burden, & Hubbard, 2006). Several individual residues in the MuSK 
ectodomain are known to be critical for MuSK activation. Isoleucine 96 is proximal to the 
external disulphide bridge of the Ig1 domain. Receptor activation was probed. This revealed 
that MuSK activation in mutant mice was abolished. Met-48 and Leu-83 in the Ig1 domain of 
MuSK are also known to be critical for MuSK activation. Substitution mutations at Met-48 and 
Leu-83 resulted in a decrease in agrin-induced receptor activation (Stiegler et al., 2006).  
Sequences located near to the first four Ig domains in MuSK are required for an agrin 
response. The fourth Ig (Ig4) domain however is only required for rapsyn interaction. This 
suggests that the MuSK ectodomain mediates agrin-induced signalling of the MuSK system 
(Zhou, Glass, Yancopoulos, & Sanes, 1999). The cytoplasmic domain of MuSK contains a 
tyrosine kinase region, which is flanked by a c-terminal tail and a juxtamembrane domain that 
has a role in agrin-mediated signalling (Willmann & Fuhrer, 2002). The juxtamembrane domain 
contains an NPXY motif that is essential in downstream signalling (Fig 1.3). Herbst and Burden 
(Herbst & Burden, 2000) showed that deletion of the juxtamembrane domain of MuSK 
resulted in the formation of an active MuSK form. Deletion of 13 amino acids from the 
juxtamembrane domain was sufficient to convert MuSK from an inactive to active form. This 
suggests that the MuSK NPXY site function is to recruit a phosphotyrosine domain binding 
protein that stimulates phosphorylation and AChR clustering (Herbst & Burden, 2000).  
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1.4.2.2 Function and Role of MuSK 
Agrin acts via the MuSK receptor complex, where MuSK acts as a co-receptor of agrin, and 
induces phosphorylation and clustering of AChRs (Glass, Bowen, et al., 1996; Herbst & Burden, 
2000). This was shown by the study of MuSK -/- mice which were shown to be devoid of agrin 
mediated AChR clustering. This is evidence for MuSK being required for AChR clustering in 
response to agrin. Agrin isoforms that are most active in AChR clustering are also the most 
active in tyrosine phosphorylation of MuSK. This indicates that MuSK is a critical component of 
the receptor complex and is critical in agrin induced AChR clustering (Glass, Bowen, et al., 
1996).  . 
 
Mice lacking the MuSK gene have impaired neuromuscular synapses indicating that MuSK is 
critical for synapse formation and maintenance. MuSK -/- muscle cells do not develop AChR 
clusters, unlike normal muscle cells. In addition, MuSK deficient mice showed signs of 
abnormal nerve terminals, providing evidence for a role of MuSK involving pre-synaptic 
differentiation (Glass, DeChiara, et al., 1996) In muscle cell culture AChR clusters are not 
formed in the absence of MuSK, even when agrin is present (Yang et al., 2001). This suggests 
that MuSK is essential for AChR clustering and is a determinant in NMJ development and 
maintenance. 
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Fig 1.3 Structure of the MuSK molecule.   
The extracellular component of MuSK contains four Immunoglobin-like domains (Ig) and the 
cysteine rich c terminal. The transmembrane domain (TM) sits between the juxtamembrane 
(JM) domain and the Ig domain. The (JM) domain contains the NPXY motif (figure modified 
from (Ghazanfari et al., 2011)).  
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1.4.3 LRP4 
Early research suggested the existence of a ‘Myotube-Associated Specificity Component’ 
(MASC) to facilitate the binding of agrin to MuSK (Glass, DeChiara, et al., 1996). A 220 kDa 
transmembrane protein called low-density lipoprotein receptor-related protein 4 (Lrp4) turned 
out to be the long elusive MASC. Thus now Lrp4 is known to be a co-receptor for agrin. Neural 
agrin forms a complex with LRP4 and MuSK that mediates MuSK activation. This was shown in 
experiments where soluble forms of LRP4 ecto- domain and agrin precipitated, suggesting that 
these two proteins interact together. In contrast, secreted MuSK ectodomain and agrin did not 
precipitate, suggesting that agrin and MuSK do not directly interact with each other (Zhang, 
Coldefy, Hubbard, & Burden, 2011).  Mouse embyros deficient in Lrp4 revealed atypical pre- 
and post-synaptic specialisations. Similar to MuSK null mutants, LRP4 mutant embryos lacked 
AChR clustering at the normal development stage. When some AChR clusters did appear later 
in development, they were not localised with nerve terminals to form a synapse. Motor axons 
exhibited extensive branching and grew past the primitive AChR clusters. Lrp4 is also required 
for synapse-specific transcription in muscle nuclei, since mice lacking LRP4 were shown, using 
in-situ hybridisation, to be unable to localise MuSK to the synapse. Immunofluorescence 
analysis revealed disruption of MuSK protein localisation to endplates  in LRP4 -/-  and also 
showed evidence of disruption of the localisation of rapsyn and utrophin to the endplate 
(Weatherbee, Anderson, & Niswander, 2006).   
 
In summary the evidence that agrin-LRP4 interacts with MuSK to initiate MuSK kinase activity 
and AChR clustering is as follows: 1) LRP4 expressing heterologous cells were found to 
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aggregate with MuSK expressing cells, suggesting that MuSK and LRP4 interact via their 
respective ecto- domains; 2) Western blots revealed co-immunoprecipitation of MuSK and 
LRP4, further suggesting interaction between the two molecules;. 3) When neural agrin was 
applied to LRP4 null myotubes it failed to stimulate MuSK phosphorylation. This was rescued 
by transfecting LRP4 back into these mutant myotubes. With the role of MuSK already stated 
earlier in this thesis, the evidence suggests that LRP4 is critical to activate MuSK and reveals 
that lack of typical pre- and post-synaptic differentiation in LRP4 mutants is due to the inability 
of agrin to activate MuSK in the absence of LRP4 (Kim et al., 2008; Weatherbee et al., 2006). 
The above evidence suggests that Lrp4 is a critical factor in NMJ development.  
 
 
1.4.4 Dok-7 
Docking protein 7 (Dok7), is a MuSK interacting cytoplasmic protein that is essential for NMJ 
development. This was shown where mice lacking Dok-7 did not form AChR clusters or 
neuromuscular synapses (Arimura et al., 2006). Dok-7 plays an essential role in regulating 
MuSK localisation, activation and response to agrin, which are all necessary in NMJ 
development.  Experiments that involved overexpression of Dok-7 resulted in multiple AChR 
clusters forming. Mouse embryos  were found to contain 1.7x more NMJs per muscle fibre. 
This was associated with increased phosphorylation of MuSK and AChR clusters. This suggests 
that over-expression of Dok7 had resulted in the activation of MuSK and enhanced NMJ 
formation, implicating Dok-7 in MuSK activation and NMJ development (Inoue et al., 2009) . In 
addition, Dok-7 controls the responsiveness of Musk to agrin.  Experiments of in Dok-7 -/- mice 
showed neural agrin was unable to induce MuSK activation and no AChR clustering was 
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observed. MuSK dependent AChR clustering was then restored with exogenous expression of 
Dok-7. Dok-7 has also been shown to have a role in regulation of MuSK localisation.  
Accumulation of MuSK and AChR transcripts in the central section of the muscle fibre was 
enhanced in Dok-7 overexpressed mice and diminished in the DOK-7 null animals. This is 
supporting evidence for DOK-7 possessing a role in regulating the location of MuSK (Inoue et 
al., 2009). DOK7 interacts with MuSK to form heterotetramers, two molecules of DOK7 bind to 
two MuSK, thereby activating the kinase function of MuSK. The evidence for this activation is 
autophosphorylation reactions within MuSK in the presence of DOK7. The rate of MuSK 
autophosphorylation was significantly increased in cells expressing extra DOK7.  In mutants 
where the 2:2 DOK7-MuSK complex was impaired, MuSK autophosphorylation was absent. 
This indicates that dimerized DOK7 juxtaposed to the two MuSK kinase domains results in 
autophosphorylation of the kinase domain loop (Bergamin, Hallock, Burden, & Hubbard, 2010).  
  
Chapter one: Introduction  
18 
 
 
 
1.4.5 Tid1 
Tumoral imaginal discs (Tid1) is a MuSK binding protein. It is the mammalian homolog of the 
Drosophila tumor suppressor gene, the heat shock protein Tid56. It is an essential component 
of the MuSK system, being crucial for synaptic development. Knockouts of Tid1 revealed 
impairment of AChR clustering and synaptic transmission. Conversely, Tid1 overexpression in 
cultured myotubes, induced agrin and MuSK independent AChR phosphorylation and 
clustering.  Tid1 is therefore essential for agrin-induced AChR clustering at the synapse. Tid1 is 
also involved in regulating Dok-7 binding to MuSK and subsequent signalling downstream of 
MuSK. Tid1 null experiments, using co-immunoprecipitation experiments, revealed markedly 
reduced association between MuSK and Dok-7 indicating that Tid1 is required for MuSK and 
Dok-7 interaction.  (Linnoila, Wang, Yao, & Wang, 2008). 
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1.4.6 Rapsyn 
1.4.6.1 Structure of Rapsyn 
The protein structure of rapsyn contains a myristolation site, several tetratricopeptide repeats, 
a coiled-coil motif, a ring zinc finger domain and a serine phosphorylation site (Fig 1.4). The 
myristoylated N-terminus is critical for targeting rapsyn to the plasma membrane (Phillips, 
Maimone, & Merlie, 1991). At least two tetratricopeptide repeats are required for rapsyn self-
aggregation. Disruption of the coiled-coil domain was seen to impair AChR clustering (Ramarao 
& Cohen, 1998). The ring zinc finger domain mediates the binding of rapsyn with β-
dystroglycan (Fig 1.4) (Willmann & Fuhrer, 2002).  
 
1.4.6.2 Function and role of Rapsyn 
Rapsyn is a 43 kDa cytoplasmic protein that can bind to the AChR and facilitate AChR clustering.. 
Overexpression of rapsyn/43kD protein in heterologous cell lines led to formation of large cell 
surface clusters of co-expressed AChRs (Froehner et al 1990; Phillips et al 1991). In addition, 
high resolution electron microscopic studies by Nigel Unwin and colleagues showed rapsyn 
forms cross-links between adjacent AChRs (Zuber & Unwin, 2013). Loss of function studies 
showed homozygous rapsyn knockouts were born in similar numbers and had similar 
appearance to wild types, but died shortly after birth. No AChR clusters were present in 
muscles of rapsyn knockout mice. This suggests that rapsyn lies along the pathway of agrin 
induction of AChR clustering (Gautam et al., 1995; Sanes & Lichtman, 2001). Motor axons in 
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rapsyn knockout mouse embryos appeared to lack differentiation grow readily in non-synaptic 
areas (Gautam et al., 1995). Agrin, which is produced by the motor nerve, increases the levels 
of rapsyn protein expression by inhibiting rapsyn proteolysis. This was shown in cultured 
myotubes exposed to agrin. However, no increase in rapsyn mRNA was detected. The increase 
in rapsyn was also observed in the presence of cycloheximide, a translation inhibitor. This 
suggests that the agrin-induced increase in rapsyn is due to a decrease in rapsyn catabolism 
(Brockhausen et al., 2008; Luo et al., 2008). Increased rapsyn expression, which can be induced 
by agrin, may function in packing AChRs tightly on the postsynaptic membrane and decreasing 
their rate of metabolism. An increased rapsyn:AChR immunofluorescence ratio was associated 
with increased AChR packing and reduced rapsyn turnover.  Thus Rapsyn and AChR 
interactions mediate AChR clustering and are promoted by agrin. (Brockhausen et al., 2008; 
Chen et al., 2007; Moransard et al., 2003).  
 
              The ability of rapsyn to crosslink AChR and linking them to the cytoskeleton may be important 
in the stability of AChRs. Moderate levels of expression of transfected rapsyn can restore AChR 
clustering in rapsyn deficient myotubes.  Although rapsyn is essential for AChR cluster 
formation, overexpression of rapsyn has been found to inhibit the agrin induced AChR 
clustering pathway. Rapsyn overexpression results in formation of discrete AChR micro-
aggregates on the post-synaptic membrane (Han et al, 2000). This may be due to the finding 
that rapsyn overexpression modifies AChR intracellular trafficking. The findings suggest that 
rapsyn may have a role in transporting newly synthesised clusters to the surface of the 
postsynaptic membrane (Han et al., 2000).  
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Fig 1.4 Structure of the Rapsyn molecule  
Figure denoting the rapsyn molecule with the myristolyation site, tetratricopeptide repeats, 
coiled-coil motif, ring zinc finger and the phosphorylation site shown (figure reproduced from 
(Willmann & Fuhrer, 2002). 
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1.4.7 Acetylcholine/CDK5 Signalling at the NMJ 
While the agrin/LRP4-MuSK/rapsyn pathway stabilizes AChR clusters, an opposing pathway 
involving Ach, the AChR and CDK5 negatively regulates AChR clustering at the NMJ. 
Acetylcholine has two major roles at the NMJ, both directly activating the cation channel of the 
AChR and indirectly dispersing AChRs from AChR clusters. The destructive pathway involves 
calpain and CDK5 to cause disassembly of AChR clusters. This was shown in experiments using 
time-lapse imaging that revealed that when myotubes were incubated with an AChR agonist 
(carbachol), their AChR clusters were dispersed (Misgeld, Kummer, Lichtman, & Sanes, 2005). 
Cyclin dependent kinase 5 (CDK5) was shown to be activated by Ach (Carbachol) and CDK5 was 
found to be critical for carbachol-induced AChR dispersal. Inhibition of CDK5 activity was 
shown to inhibit Ach-induced dispersal of AChR clusters. Thus Ach activates CDK5 and this 
seems to negatively regulate AChR clustering.  
Calpain is activated by calcium influx following cholergenic stimulation. Calpain, in turn, is a 
potent activator of CDK5. Treatment with a cholinergic agonist caused an increase in calpain 
activity in myotubes. Calpain inhibitors prevented AChR cluster dispersal in such cultures. 
However, calpain was shown to interact with rapsyn and this binding inhibited calpain’s 
protease activity. Thus, rapsyn appears to stabilise AChR clusters by inhibiting calpain activity. 
An assay of mouse brain lysates, with and without rapsyn, were used to compare calpain 
activity. Calpain activity which was observed in the assay not containing rapsyn appeared to be 
inhibited in the presence of rapsyn. This showed that rapsyn suppressed calpain activity via 
interaction. The above is evidence for the role of ACh/CDK5-calpain in post-synaptic 
differentiation of the NMJ  (Chen et al., 2007). The opposing agrin/MuSK/rapsyn and 
ACh/AChR/calpain/CDK5 pathways are summarised in (Fig 1.5). 
  
Chapter one: Introduction  
23 
 
 
 
 
 
Fig 1.5 The opposing signaling systems that regulate postsynaptic AChR clustering at the 
NMJ.  
Agrin is shown as the primary regulatory molecule of the MuSK system. Lrp4 and MuSK act as 
agrin co-receptors. Activation of MuSK leads to AChR clustering. Rapsyn stabilises the NMJ by 
anchoring AChRs to the cytoskeleton and inhibiting calpain activity. Calpain activated by 
cholinergic stimulation inhibits/disperses AChR clustering via the effects of CDK5.(Ban & 
Phillips, 2015) 
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1.4.8 Regulation of MuSK by Other Signalling Molecules  
The Wnts are a family of extracellular signalling molecules with roles in neural development, 
navigation and synaptogenesis. The Wnt ligand binds to its frizzled receptor (Fz) to form a Wnt-
Fz complex activates a cytoplasmic protein called dishevelled (DVL) that brings together 
components for effective signal transduction. Several components of the Wnt-Fz signalling 
system have been implicated in agrin-MuSK signalling. Inhibiting the interaction between 
MuSK and DVL disrupts AChR clustering in myotubes, indicating that DVL has a role in 
clustering AChRs at the NMJ. Agrin activates the serine/threonine kinase P21-activated 
kinase 1 (PAK1) molecule via DVL. Inhibiting PAK1 has been shown to impair AChR clustering    
(Luo et al., 2002). This suggests that PAK1 also has a critical role in the MuSK system.  
Wnt signalling has also been shown to have a role in negatively regulating AChR clustering by 
inhibiting rapsyn expression. Specifically, treatment of myotubes with Wnt3a inhibited AChR 
clustering and caused a decrease in the protein level of rapsyn. Subsequently, overexpression 
of rapsyn, by use of a promoter not responsive to Wnt3a, alleviated this impairment effect of 
Wnt on AChR clustering. Thus, Wnt3a expression acts to inhibit and disperse AChR clusters at 
the NMJ by down regulating rapsyn expression. This provides evidence for roles of Wnt-DVL-
PAK as part of the MuSK signalling system (Burden, Yumoto, & Zhang, 2013; Ciani & Salinas, 
2005; Linnoila et al., 2008; Z. G. Luo et al., 2002; Wang et al., 2008).  
 
Cytosolic Src family kinases (SFK) act as part of the MuSK system with roles in regulating agrin-
induced AChR phosphorylation, cytoskeletal anchoring and clustering. Protein kinase assays 
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revealed a significant increase in the activity of AChR-associated SFKs when cells were treated 
with agrin (Mittaud, Marangi, Erb-Vogtli, & Fuhrer, 2001). This suggests that SFK is at least 
partly activated by agrin. Inhibition of SFK resulted in reduced AChR phosphorylation, 
clustering and anchoring. This is supported by several lines of evidence. Firstly, inactive MuSK 
was shown to be phosphorylated when co-expressed with SFKs. This provides evidence that 
MuSK can be phosphorylated by SFKs and is a likely substrate for SFK. Secondly, AChR 
phosphorylation and clustering was inhibited with the use of a SFK-specific inhibitor, namely 
Protein phosphatase 1 (PP1). Finally, the number of ACHRs that were anchored in the plasma 
membrane (resistant to detergent extraction) was markedly reduced when the same SFK 
inhibitor was applied compared to without (Mohamed, Rivas-Plata, Kraas, Saleh, & Swope, 
2001). The above evidence provides a role for SFKs in agrin induced MuSK phosphorylation and 
AChR phosphorylation and stabilisation.  
 
Casein kinase 2 (CK2) is a highly conserved, ubiquitous serine/threonine kinase expressed in all 
eukaryotes. CK2 colocalises with MuSK at post-synaptic specialisations and is known to be able 
to interact with MuSK in vitro. Serine phosphorylation of the intracellular domain of MuSK 
mediated by CK2 is critical for normal AChR clustering and maintenance. The use of a yeast 
two-hybrid assay revealed the CK2β subunit interacts with the phosphorylated form of MuSK, 
suggesting a role for the interaction of CK2 and MuSK. Serine to alanine mutations within the 
kinase insert of MuSK reduced the phosphorylation of MuSK compared to wild-type MuSK, 
suggesting that CK2 has a role in phosphorylation of these serine residues. 
Immunohistochemical staining revealed that CK2 co-localises with AChR clusters in a range of 
muscles.  Studies involving knockdown of CK2 in cultured myotubes resulted in impaired AChR 
clustering. The number of clusters observed was similar but the average size of AChR clusters 
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was decreased. This suggested fragmentation of the endplates. In addition, the presence of a 
CK2 inhibitor resulted in disappearance of AChR clusters in myotubes. This suggests a role for 
CK2 in AChR cluster maintenance (Cheusova et al., 2006). 
 
Abl kinases are non-receptor tyrosine kinase that act downstream of MuSK facilitating AChR 
clustering. Several lines of evidence support this role for Abl.  Firstly, immunohistochemical 
staining  revealed that Abl kinases are localised at the NMJ.  Second, Abl kinases mediate agrin 
induced AChR clustering in myotube culture. This was shown where neural agrin appeared to 
produce significantly reduced number of AChR clusters in the presence of an Abl family kinase 
inhibitor. MuSK and Abl1 form a complex and cross-phosphorylate each other, leading to 
enhanced MuSK kinase signalling.  Expression of while wild-type MuSK in human embryonic 
kidney cells, resulted in phosphorylation of Abl. In comparison, expression of kinase-defective 
MuSK did not result in Abl phosphorylation. Similarly, Abl was observed to phosphorylate 
MuSK, whereas the kinase-defective form of Abl was not able to cause MuSK phosphorylation.. 
Abl co-immunoprecipitated only with the kinase-functional form of MuSK, providing evidence 
for the two forming a stable complex. The above evidence suggests that Abl kinase activity is 
critical for AChR clustering and the enhancement of MuSK phosphorylation and subsequent 
signalling downstream (Burden, Fuhrer, & Hubbard, 2003; Finn, Feng, & Pendergast, 2003).  
 
Calcium has a complex role in the MuSK system that is separate from its role in the destructive 
calpain/CDK5 pathway discussed above. In cultures of myotubes, extracellular calcium is 
required for the agrin-induced formation of the active MuSK complex and intracellular calcium 
regulates phosphorylation and clustering of AChRs. Agrin induced MuSK activation in cultured 
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myotubes was completely blocked when extracellular calcium was removed. However, MuSK 
activation was only slightly reduced when intracellular calcium was blocked. This was done by 
clamping calcium levels with the use of the chelator BAPTA. Myotubes loaded with BAPTA are 
known to be able to clamp intracellular calcium fluxes. (Deisseroth, Bito, & Tsien, 1996) This 
suggests that calcium fluxes serve as a control point in the MuSK system for post-synaptic 
differentiation (Borges, Lee, & Ferns, 2002).   
 
HSP90β has been shown to regulate rapsyn turnover. Increased levels of HSP90β are present at AChR 
clusters. Heat shock protein is involved in rapsyn stability and folding. Rapsyn stability is 
critically dependent on HSP90β, indicating a role for HSP90β in the formation and maintenance 
of NMJ. After myotubes are stimulated with neural agrin, HSP90β interacts with rapsyn 
resulting in recruitment of HSP90β to the AChR cluster (S. Luo et al., 2008).   
Aspects of the combined MuSK signalling complex is described in (Fig 1.6). 
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             Fig 1.6 Aspects of the MuSK signalling complex as induced by agrin.  
 1) Formation of the agrin-LRP4-MuSK complex recruits DOK7; 2) MuSK-DOK7 interaction 
results in tyrosine autophosphorylation of MuSK;  3) This recruits and activates non-receptor 
tyrosine kinases Src and Abl; 4) Src and Abl promote MuSK activation; 5) Abl & Src also 
contribute to AChR phosphorylation and cluster stability; (B) 7&8) GTPases such as Rac/Rho 
promote AChR clustering and activate PAK kinase; 9) PAK1 kinase also promotes AChR 
clustering; 10) Tid1 also contributes to AChR clustering;  11) Rapsyn contributes to AChR 
stability by forming cross-links with AChRs and linking them to the cytoskeleton (modified from 
(Ghazanfari et al., 2011)  
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1.5 Development and Maintenance of the Neuromuscular Junction 
1.5.1 Developmental changes at the neuromuscular junction 
1.5.1.1 Development of the synapse  
Synaptogenesis occurs when the growth cones of motor axons  project along a stereotyped 
pathway from the spinal cord to muscle. Once a motor neuron’s growth cone comes into 
contact with a newly formed myotube, synaptic transmission begins. An immature synapse is 
characterized by the absence of certain pre and post-synaptic differentiation and low efficacy 
of synaptic transmission. After a period, of about a week, a fully functional, though still 
immature, synapse is evident (Sanes & Lichtman, 1999). Spatial patterning of AChRs on muscle 
fibres was until recently thought to depend on signals from the motor nerve (McMahan, 1990). 
However, AChR pre-patterning in muscle fibres can occur in the absence of motor innervation. 
As motor neurons die as part of the normal ageing process, these effects could be due to 
periods of denervation. In embryonic mice with undifferentiated motor nerve terminals, AChR 
clusters were still prepatterned. This suggests that initial pre-patterning does not require the 
input of nerve signalling. However, AChR clusters in the central zone of AChR expression were 
much larger than normal and AChR clusters were still seen in the central regions of the fibre. 
This suggests that although muscle prepatterning occurs in a nerve independent manner, 
nerve signalling refines this process (Yang et al., 2001).  
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Schwann cells have an important role in reinnervation and may guide regenerating motor 
axons to original synaptic sites. Experiments in which extra Schwann cells that were implanted 
into innervated muscle led to sprouting of nerve terminals upon contact with an axon or nerve 
terminal with the Schwann cell processes. Partial denervation of the soleus muscle of adult 
rats resulted in the sprouting of elaborate processes from Schwann cells, with multiple located 
in several endplates and greater sprout length, with Schwann cells extending further from the 
outlines of the endplate. In addition, partially denervated muscles that were double labelled 
with markers for neurofilament and Schwann cells revealed that every terminal sprout was 
associated with a Schwann cell process. Finally, Schwann cells were found to have induced 
sprouting of axons and axon terminals. This was shown when transplantation of a nerve 
branch devoid of axons into the soleus, Schwann cell processes had grown to reach several 
endplates. Nodal and terminal axon sprouts grew from these endplates. These axons grew 
from the endplate and through the Schwann cell processes towards the nerve stump. The 
sprouting was confined to the narrow zone of Schwann cell contact. This is evidence that 
Schwann cell can induce and guide axonal sprouting in muscle (Son & Thompson, 1995). 
 
Studies in mouse embryos support the idea that neural agrin and MuSK signalling co-ordinates   
development of the NMJ. Agrin is synthesized by motor neurons and transported down the 
axon. In situ hybridisation showed agrin mRNAs in motor neurons. Moreover the Golgi 
apparatus of motor neurons were stained by anti-agrin antibodies. This strongly suggests that 
motor neurons synthesise agrin. Agrin is then transported down the axon to the NMJ. After the 
frog sciatic nerve was ligated, anterograde axonal transport is blocked at the ligation. Anti-
agrin antibodies were shown to stain the proximal (cell body) side of the ligation. By 
comparison there were very few stained axons on the terminal side of the ligation. This 
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suggests that agrin is synthesised in the cell bodies of motor neurons and is transported down 
the axon in an anterograde direction (Magill-Solc & McMahan, 1990). Furthermore, agrin is 
known to be a necessary component in synaptic differentiation and in stabilising the 
embryonic NMJ. Agrin was shown to regulate motor neuron induced AChR clustering in cell 
culture and in mouse embryos as discussed above. MuSK deficient mice were unable to form 
NMJs and died at birth. These MuSK mutants lacked arborized nerve terminals and clustered 
AChRs. The nerve branch was abnormally long, extending throughout the muscle rather than 
terminating near the main intra-muscular nerve (DeChiara et al., 1996). This suggests that 
MuSK is critical for normal pre- and post-synaptic differentiation at the NMJ in vivo. 
Genetic studies have similarly shown that Lrp4 is required for NMJ formation. Mice that lack 
Lrp4 lack normal NMJs and die shortly after birth, similarly to MuSK knockouts (Weatherbee et 
al., 2006). Lrp4 is necessary for agrin induced MuSK activation and AChR clustering in myotube 
cultures and can induce MuSK signalling (Kim & Burden, 2008). 
 
The role of Wnt family ligands in NMJ formation has been studied in zebrafish embyros. A 
domain of zebrafish MuSK interacts with Wnt11r and Dvl signalling is implicated in the 
formation of AChR clusters and is involved in motor axon guidance (Jing, Lefebvre, Gordon, & 
Granato, 2009). Conflicting results have been reported on the role of Wnt signalling and AChR 
formation. In one study, treatment with Wnt3 was shown to inhibit AChR clustering and 
decrease rapsyn expression. This suggests that Wnt proteins have a role in negatively 
regulating AChR cluster formation by suppressing rapsyn expression via b-catenin-dependent 
signalling (Wang et al., 2008). However, another study reported Wnt3 induces AChR 
microclusters and promotes agrin-induced clustering. Muscle from mutant mice, with a 
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deficiency in Wnt signalling, showed changes in AChR cluster distribution and endplate band 
with in comparison to wild type controls. A significant increase in the number of AChR clusters 
was also reported when an agrin-Wnt combination was added to myotubes rather than just 
agrin alone. This study suggests that Wnt signalling is required to promote post-synaptic 
differentiation and has a positive role in regulating AChR clusters with agrin. (Henriquez et al., 
2008). 
 
 
 
1.5.2 Postnatal remodelling of the developing Mouse Neuromuscular Junction 
Early in NMJ development (around birth) each motor endplate is innervated by multiple axons. 
A transition occurs from this poly-neuronal innervation of endplate AChRs to each endplate 
being solely innervated by one motor axon. Synaptic elimination from polyneuronal 
innervation to single innervation is largely complete by 3rd week of post-natal development in 
rodents. (Rosenthal & Taraskevich, 1977).  During this transition AChRs are removed from 
certain regions of the developing endplate and begin clustering in other areas. At birth, AChRs 
are localised at irregular patches within a spoon shaped plaque. Over several weeks, this 
plaque perforates so that the regions that maintain the developed NMJ begin to resemble a 
pretzel shape. As the NMJ develops, gutters and folds are seen in the post-synaptic regions 
(Marques, Conchello, & Lichtman, 2000).  
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1.6 The Neuromuscular Junction and Disease 
1.6.1 Changes of the Neuromuscular Junction with aging 
Physiological studies have provided evidence for the decline of muscular performance after 
the age of fifty. Aged people have been shown to have a decrease in muscle mass, strength, 
power and are more prone to fatigue. (Faulkner, Larkin, Claflin, & Brooks, 2007). This has been 
attributed to change in both muscle and nerve. Several structural and functional changes that 
occur at the NMJ between young-adult and elderly animals. These are mainly regressive 
changes that inhibit proper functioning of the NMJ including decreased synaptic efficiency and 
subsequent muscular performance in aged muscle. Early studies have shown that post-
synaptic area and membrane length was significantly reduced in aged NMJs when compared to 
younger NMJs (Tse et al., 2014). Electron micrographs also revealed a decrease in nerve 
terminal area in autopsied human subjects. The number of AChRs per junction were also 
shown to reduce with age. (Arizono, Koreto, Iwai, Hidaka, & Takeoka, 1984). In mice, the life 
span is about 2 years. Comparison of young adult mice (1-3 months old) with aged mice (24-28 
months old) revealed withdrawal of nerve terminal, axonal swelling, nerve sprouting, synaptic 
detachment and fragmentation of post-synaptic clusters in a fraction of NMJs (Valdez et al., 
2010). A significant decrease in AChR and nerve area per endplate was observed in this study 
between young and elderly mice. There is an increase in motor unit size and a decrease in 
motor neuron number during normal ageing. In another study the large AChR plaque again 
fragmented into multiple AChR clusters and a significantly reduced area of AChR was observed 
to be covered by the presynaptic nerve (Fig 1.7) (Cheng et al., 2013).  
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                                Age (Months) 
Fig 1.7 Changes in overlap, AChR and nerve area at the NMJ with age. 
 
 Significant decreases in AChR, nerve and overlap area were observed in the aged NMJ as 
compared to young. This implicates structural changes at the NMJ that occur with the ageing 
muscle. (Figure modified from (Cheng et al, 2013. PLoS One, 8(7)) 
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1.6.2 Disorders of the NMJ 
1.6.2.1 Myasthenia Gravis 
Myasthenia gravis is the most common disorder of the NMJ, affecting approximately 10-20 in 
every 100,000 people. It is characterised by skeletal muscle weakness and fatigability due, in 
a majority of cases, to anti-AChR antibody that attack endplate AChR clusters. Myasthenia 
gravis is characterised by a decrease in the amplitude of the compound muscle action potential 
(CMAP) during repeated stimulation of the motor nerve at low frequency (3Hz). Ptosis and 
diplopia occur in the majority of cases. Facial and bulbar muscles may also be affected. 
Generalised weakness occurs in 85% of patients where it may affect the limbs, diaphragm and 
neck extensors. Weakness of respiratory muscles may become weak enough to require 
mechanical stimulation. The main abnormality of myasthenia gravis is the reduction in number 
and/or function of AChRs. The lack of adequate interactions between the acetylcholine 
neurotransmitter and its AChR receptor results in impaired synaptic transmission. Efficient 
synaptic transmission is vital for proper muscle contraction. Endplate potentials are not able to 
reach thresholds in many cases, preventing the triggering of action potentials in muscle fibres. 
This failure of synaptic transmission results is clinically manifested as muscle weakness 
(Drachman, 1994).   
 
While most cases of myasthenia gravis are caused by anti-AChR IgG, many of the remaining 10-
20% of cases that don’t exhibit antibodies against AChRs, instead show anti-MuSK antibodies. 
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Mouse models for anti-MuSK antibody myasthenia gravis revealed that anti-MuSK 
autoantibodies resulted in NMJ failure by interrupting the MuSK signalling pathway .  
Immunoglobulin G from anti-MuSK-positive myasthenia gravis patients was injected into mice 
daily over a 14 day period. The area and intensity of endplate AChR staining was observed to 
be significantly reduced by the anti-MuSK injections. In addition, pulse labelling of endplate 
AChRs revealed an accelerated loss of existing AChRs without a compensating increase in new 
AChR formation. Endplate immunostaining for MuSK, activated src, rapsyn and AChR staining 
all had significantly reduced intensities. This study, with the use of this mouse model, showed 
that anti-MuSK IgG suppresses MuSK signalling activity and AChR retention at the NMJ 
(Ghazanfari, Morsch, Reddel, Liang, & Phillips, 2014).  
 
Active immunisation with the extracellular domain of MuSK is known to be able to generate 
Myasthenia gravis in mice. A/J mice were immunised with the extracellular domain of rat 
MuSK and compared with control mice. These animals showed severe signs of weakness and 
pronounced loss of body weight. Electrophysiological recordings from muscle and single 
muscle fibres suggest loss of synaptic AChRs. Endplates appeared to have a substantial 
reduction in the number of AChRs compared to control. The diaphragm muscle had more than 
90% loss of AChR clusters. This suggests that the postsynaptic organisation was disrupted at 
the NMJ. This study, with the aid of the mouse model, showed that anti-MuSK antibodies can 
induce Myasthenia gravis (Jha et al., 2006). 
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1.6.2.2  Congenital myasthenia caused by mutations of genes in the MuSK 
pathway 
Congenital myasthenic syndromes (CMS) are inherited diseases of the NMJ that result from 
mutations that cause impairment in proteins associated with the NMJ. CMS can cause 
weakness, fatigue and may perturb NMJ function so severely as to be lethal. Several CMS 
variations are caused by mutations, in genes associated with the MuSK pathway including; 
agrin, MuSK, rapsyn and DOK7 (Bogdanik & Burgess, 2011). Gene analysis revealed a missense 
mutation affecting the AGRN gene in a patient with identified CMS. A muscle biopsy revealed 
major disorganisation of the NMJ, including changes in the nerve terminal and synaptic 
gutters. Injection of wild type agrin into the rat soleus muscle resulted in formation of non-
synaptic AChR clusters. However, mutated agrin injections resulted in features seen in the CMS 
patient. This suggests that a mutation affecting agrin is a cause of CMS and impairs the ability 
of agrin to maintain the NMJ (Huze et al., 2009). 
 
Mutations of MuSK are another known cause of CMS. (Maselli et al., 2010) identified two 
missense mutations located in the kinase domain of MuSK. Decreased miniature endplate 
potential amplitudes, reduced endplate size and underdevelopment of synaptic folds was 
observed. Severe impairment of MuSK phosphorylation, AChR clustering and MuSK-DOK7 
interaction was seen. This suggests that MuSK mutations are a determinant of CMS. 
 
DOK7 is a major locus for mutations that result in CMS. A variant of mutant DOK7 results in 
reduced MuSK activation and subsequent AChR clustering. This suggests that impaired DOK7-
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MuSK signalling results in impairment of the NMJ and muscle weakness. It was also shown that 
DOK7 CMS patients have smaller, simplified NMJs (Yamanashi, Higuch, & Beeson, 2008).  
 
Rapsyn is also a known locus for CMS. Rapsyn mutations are known to cause AChR deficiency 
and CMS in humans. Expression studies in HEK cells reveal that rapsyn self-association is 
normal. However, co-clustering of AChR with rapsyn is diminished. This gives evidence for 
rapsyn mutations may result in CMS. 
 
The above are evidence for mutations that result in reduced and/or altered expression of 
genes in the MuSK pathway are known to cause CMS.  
1.6.2.3 L25 Mouse Model Line 
The L25 line of transgenic mice develop spastic paralysis suggesting that they may offer 
potential as a new mouse model of Motor neuron disease. The L25 line was generated via 
random insertion of a DNA cassette containing the sef promoter gene into the mouse nuclear 
genome. Sef is a receptor tyrosine kinase (RTK) signalling antagonist. Sef overexpression in the 
lens of transgenic mice led to impaired lens and eye development. Sef inhibited fibre cell 
elongation and differentiation and increased apoptosis. This indicates that sef is an important 
negative regulator of growth factor signalling (Newitt et al., 2010). However, this transgene is 
expressed under a lens-specific promoter and would therefore not be expected to have any 
gain of function effects in muscle or nerve. 
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 Approximately one quarter of the offspring from L25+/- x L25+/- mating developed symptoms 
including tremor and spastic paralysis , presumably due to the transgene fortuitously 
disrupting an endogenous gene that is important for motor control. The mice displayed 
significantly reduced motor activity and a decline in body weight was observed. The first signs 
of dysfunction were observed at 3 weeks where a subset of animals showed a fine, sustained 
tremor and hind limb retraction when held by the tail. Mice had to be euthanased at about 2-3 
months of age due to spastic paralysis of the hind limbs. This L25 line may provide an 
additional model of MND. (Kichkin, E University of Sydney Honours thesis 2014). Since MND 
often involves loss of neuromuscular connections and degeneration of the spinal motor 
neurons part of my project was to investigate the integrity of NMJs in affected L25 mice. 
Motor neuron disease is a broad class of neurodegenerative disorders, involving impairment of 
the upper and lower motor neurons. Clinical manifestation of upper motor neuron 
degeneration is commonly observed with muscle spasticity as seen in the L25 line. Lower 
motor neuron degeneration clinically manifests as muscle weakness and atrophy {Durand, 
2006}. The aim of the L25 study was to determine whether the L25 line is useful as a murine 
model for the study of MND. Therefore, to identify the effect of the lower motor neurons in 
L25 affected animals, I applied similar techniques to the ones used in the earlier chapters of 
this thesis to determine whether lower motor neurons were similarly impaired in L25 affected 
animals as in MND. 
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1.7 Aims 
In this thesis I have helped develop and apply confocal microscopic methods to measure the size 
and integrity of the mouse NMJ with two main aims: 
1) Influence of the MuSK system gene expression level upon the aging NMJ: Since NMJ integrity 
declines with age, and since loss-of-function alleles for agrin, MuSK, rapsyn and DOK7 occur in 
carriers amongst human populations I aimed to assess the influence of reduced gene dosage of 
agrin, MuSK and rapsyn (heterozygotes versus wild-types) upon the size and integrity of the 
mouse NMJ (Chapter 3). I study whether reduced gene dosage of major proteins of the MuSK 
system exacerbate and/or prematurely reveal age associated changes of the NMJ. I also 
investigated the impact of elevated MuSK expression level (expression of recombinant MuSK 
from adeno-associated viral vector) upon NMJ size and whether this delays or prevents age 
associated changes at the NMJ (Chapter 4).  
2) Does hind limb paralysis in the L25 transgenic mouse involve denervation of motor 
endplates? To test this, in chapter 5 I apply the same quantitative methods to test for 
abnormalities in L25 transgenic mice that became paralysed. This served as a first test for 
possible involvement of the lumbar motor neurons 
 
 
 
 
. 
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 Chapter 2: Methods.  
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2.1 Mice and Muscle Samples Used in Experiments 
Mice and muscle samples used in the following experiments were obtained from a variety 
sources. The agrin +/- and rapsyn +/-, along with some wild-type controls were supplied by 
A/Prof Peter Noakes from the University of Queensland. MuSK experiments used muscles 
derived from female 2 month C57Bl/6J from the animal resources centre Perth, which were 
aged in the Bosch animal facility at the University of Sydney. Muscles used for the L25 
experiments were taken from mice used in previous research for Eva Kichkin’s honours thesis 
as described in (Reneker et al., 2004). Additional muscle tissue were taken from 6 weeks old 
C57BL/6J mice from honours student Joshua Way’s experiments. Specific details of animals 
used in the following experiments are detailed in Figure 3.1, figure 4.1 and section 5.2. 
2.2 Muscle Dissections 
Prior to dissection of the mouse Tibialis anterior (TA) muscles, the mice were transferred from 
Bosch animal facility at the University of Sydney to the lab where they were sacrificed. Mice 
were sacrificed with an overdose of pentobarbitone. This is administered with an 
intraperitoneal injection (30mg/kg). The mouse was then placed in a cage with access to the 
mouse by the researchers. A foot withdrawal reflex test is administered every minute by 
pinching the leg of the mouse. A corneal blink response test was performed in conjunction 
with the foot withdrawal test until no reflex remained to gauge if the mouse is deceased. This 
involves stimulating the corneal blink response by using forceps to gently touch the cornea. 
These reflexes are tested every 60 seconds until no reflex remained. If either of these reflexes 
is present, then the mouse is not considered deceased and may not be dissected. An additional 
dose of pentobarbitone may be administered if the mouse still exhibits reflexes after a 
prolonged period of time.  
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After no reflex remained, the animal was pinned down on a Styrofoam stage and the hair 
surrounding the leg and ankle of the mouse was removed using a hair removal cream, such as 
Nair. With the use of surgical scissors and forceps, an incision was made through the skin 
covering the TA muscle, being careful not to damage the muscle.  Blunt forceps were used to 
separate membranes and surrounding tissues from the TA. The distal and proximal 
attachments of the TA were cut to remove it from its point of insertion and origin. The muscle 
was then temporarily stored in 0.1M PBS (1x PBS) solution whilst further dissections, that are 
required for the experiment, are carried out. It was then immediately fixed as described below. 
 
  
Chapter Two: Methods  
44 
 
2.3 Fixing, Cryoprotection and Storage of the Tibialis Anterior Muscles 
Muscles were fixed to preserve integrity. Immediately post-dissection, each muscle was 
immersion fixed in approximately 1ml of 2% Paraformaldahyde (w/v) diluted in PBS solution in 
an Eppendorf tube for 3 hours. Muscles were then washed in 3 changes of ~1ml PBS over 30 
minutes. PBS solution was changed every 10 minutes. Muscles were then placed in, clearly 
labelled, individual Eppendorf tubes containing 20% sucrose w/v in PBS overnight at 4 degrees 
Celsius.  
After ensuring that the muscle had clearly sunk in the solution (i.e. was at a similar density to 
the sucrose solution) the muscle was frozen. Liquid nitrogen (NO2) is obtained from storage 
dewars and transported to the laboratory work station in liquid nitrogen canisters. Liquid 
nitrogen is then placed into a shallow Styrofoam container. A smaller plastic container that can 
easily fit in the Styrofoam container, and can withstand low temperatures without breaking, is 
placed in the centre of the Styrofoam container. Isopentane, used as a cryoprotectant to 
prevent cell degradation during the freezing process, is placed in the smaller container. The 
isopentane was allowed to cool until micelle clumps were observed in the solution.  
Freezing moulds consisting of folded aluminium foil measuring 2 cm x 1.5cm were used to 
contain the tissue block. A marked piece of nitrocellulose paper is placed face down to be used 
as a guide for determining the orientation of the block. Optimal cutting compound (OCT) is 
poured into the mould at a depth of approximately one quarter of the moulds height and 
clearly covering the entire paper. The mould is then placed in the container of isopentane 
where it is kept stable and level during the freezing process. The freezing process is completed 
when the OCT changes from a translucent compound to a clearly opaque one. It is important 
that the mould is not left for too long after this process as the OCT block is prone to cracking. 
The mould is removed from the containers and the muscle is placed on the frozen OCT 
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compound where it is aligned with the guide marked on the paper. The TA muscle is then 
added to mould, following the orientation guide markings. OCT is added to cover the entire 
muscle. The mould containing muscle and OCT is then placed back into the isopentane until 
the block is opaque. A drop of water or PBS is then placed into a clearly labelled 2mL 
Eppendorf tube to prevent desiccation during prolonged -80 C storage. Excess areas of the 
block are trimmed, taking care to not remove any muscle, and shaped to ensure that the guide 
for cutting is observed. The tube is then stored in liquid nitrogen until transferred to -80 C 
storage. Information such as mouse age, date of dissection and location of stored muscles are 
saved on a spreadsheet located on the database. This was accessed via the online server 
named ‘Phillip’s Lab’ and with a backup on the local desktop. 
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2.4 Cryosectioning and Immunohistochemical staining of Muscle 
Samples 
A canister of liquid nitrogen was used to transfer frozen muscle blocks from -80 C storage to 
the cryostat workstation. The cryostat (Leica Microsystems; Leica CM3050S) had its chamber 
temperature maintained at -20 C and the specimen temperature at -19 C. The frozen blocks 
had their temperature equilibrated in the chamber prior to sectioning. The block was then 
frozen onto the chuck using OCT in an orientation that would allow transverse or longitudinal 
sections to be obtained as required. Longitudinal cryosections of muscles were cut at 20 µm 
whilst transverse cryosections were cut at 12 µm. These sections were mounted onto polysine 
coated microscope slides (Thermo Scientific; Menzel-Glaser Polysine adhesion slides). 
Sections were allowed to dry onto the slides at room temperature for 30 minutes. The sections 
were then washed in PBS Phosphate Buffered Saline (PBS) for 30 minutes, with the solution 
changed every 10 minutes. Slides were then placed in coplin jars containing 0.1M glycine 
dissolved in PBS for 30 minutes. Slides were then placed in PBS-containing coplin jars for 10 
minutes to remove any excess glycine. Lipid extraction was performed by immersing slides in -
20 C methanol for 7 minutes. The slides were then washed in PBS for 20 minutes with a 
change in solution at the 10 minute mark. Each slide, one by one, was dried around its edges, 
placed sections faced up in a humidified chamber and 12.5 µL blocking solution  containing 
PBS, 2% Bovine serum albumin (BSA; Sigma; 30% w/v), 0.2% triton-X100 (ICN Biochemicals, 
Ohio) was pipetted onto each individual section. The slides were then incubated in the 
humidified chamber for 1 hour at room temperature. Post incubation, excess blocking solution 
was drawn off with a Kimwipe (Kimberley-Clark Professional, 21cm x 12cm, ProSciTech), being 
careful to not allow section to dry out or be damaged. Each section was then carefully 
overlayed with 12.5 µL primary antibody diluted at 1:200 in blocking solution (Life 
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technologies; Rabbit polyclonal anti-synaptophysin |Millipore; Anti-rapsyn-FITC clone). Refer 
to table 2.1 for list of antibodies used. Sections are then incubated overnight in the humid 
chamber at 4 C. The lid of the humid chamber was covered in aluminium foil to prevent 
antibody photobleaching.  
The following day slides were washed in PBS for 30 minutes with the solution changed every 
10 minutes. Excess PBS was again gently removed from slides, one by one, and sections were 
then overlayed with 12.5 µL of a mixture of blocking solution, alexa-α- Bungarotoxin and 
secondary antibodies. Refer to table 2.1 for a detailed list of antibodies used. Sections were 
then incubated for 1 hour at room temperature in a humid chamber covered with aluminium 
foil. The slides were washed in PBS for 30 minutes with a solution change every 10 minutes. 
Excess solution was then carefully removed using a Kimwipe and each slide were mounted 
with DABCO, an anti-fade glycerol based mounting medium (Sigma Aldrich; 1, 4 Diazabicyclo 
[2.2.2] octane. Enough DABCO is pipette onto the sections to ensure sections are entirely 
covered. This ensures that sections are protected against fluorescence fading due to light 
sensitivity. Slides are then covered with glass cover slips (Thermofisher/ Menzel Glaser). Excess 
DABCO is gently removed using Kimwipes. Clear nail polish is applied to the edges of the cover 
slips to retain them in place. Slides are stored in plastic slide holders at 4 C away from light 
until further use. Imaging of slides is completed within 2 weeks to ensure samples have not 
bleached.  
 
Since MuSK-GFP is emitted at the wavelength of 488 nm, FITC could not be used as a suitable 
secondary antibody for the MuSK-GFP experiments. This necessitated the use of antibodies 
that emit fluorescence at a wavelength different enough from the 488 nm wavelength to allow 
for adequate imaging. For such experiments sections were incubated with 12.5 µL of a mixture 
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of blocking solution, Alexa-647 α-bungarotoxin (BGT; 1:200; Molecular Probes) and Cy3 
conjugated donkey anti-rabbit secondary antibody (1:200). Slides are then similarly processed 
as described above.  
Control slides are prepared with every experiment to ensure antibody-receptor specific 
binding is occurring. Slides containing no primary antibodies (anti-synaptophysin or anti-
rapsyn) but containing α-bungarotoxin were prepared. Additional slides acting as secondary 
antibody controls were also prepared.  
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Table 2.1 Antibody staining sequence used in the results chapters 
 Chapter 3 
Agrin +/- Expt. 
Chapter 3 
Rapsyn +/- 
Expt. 
Chapter 4 
MuSK-GFP Expt. 
Chapter 5 
L25 Expt. 
Primary 
Antibody  
Rabbit anti-
Synaptophysin 
(Invitrogen) 
1:200 dilution 
Anti-Rapsyn 
(FITC 
conjugated-
mab1234 
(Millipore ) 
1:200 dilution 
Rabbit anti-
Synaptophysin 
(Invitrogen) 
1:200 dilution 
Rabbit anti-
Synaptophysin 
(Invitrogen) 
1:200 dilution 
Secondary 
Antibody  
FITC-conjugated 
anti-rabbit (1:250 
dilution) 
(Jackson 
immunoResearch 
Laboratories) 
No secondary 
Incubation 
Cy3 conjugated 
donkey anti-
rabbit secondary 
antibody 
1:200 dilution 
(ABACUS ALS) 
FITC-conjugated  
anti-rabbit 1:250 
dilution 
(Jackson 
immunoResearch 
Laboratories) 
AChR 
labelling 
(included in 
secondary 
incubation) 
Alexa-555-α-
Bungarotoxin 
1:200 dilution 
(Invitrogen) 
Alexa-555-α-
Bungarotoxin 
1:200 dilution 
(Invitrogen) 
Alexa-647-α-
Bungarotoxin 
1:200 dilution 
(Invitrogen) 
 
Alexa-555-α-
Bungarotoxin 
1:200 dilution 
(Invitrogen) 
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2.5 Confocal settings for enface Imaging of Endplates 
The Leica SpeII confocal microscope, located at the Bosch AMF, was used to obtain Z –stacks of 
en face images of endplates from longitudinal sections of the muscle. To minimise subjective 
bias, each slide was coded prior to imaging. This was performed by an individual not involved 
in the experiment (this was completed by Nigel Tse, Joshua Way or Joanne Ban). Microscope 
settings were selected on the basis of producing the best quality image for analysis while using 
the least amount of time to image. This was important as approximately 5-7mins was required 
to image each endplate and sessions on the microscope was limited.  The 63x oil objective was 
used to give the best quality image and size of endplate to be measured. A resolution of 1024 x 
1024 and a scan speed of 600Hz resulted in publishable quality images gained using the 
minimum time to image the endplate. Increasing the number of scans averaged is one way to 
reduce the background noise in a scanning confocal image. Pilot experiments showed that 
averaging 4 scans and a scan speed of 600 Hz was sufficient to minimise background noise. A 
zoom factor of 2 was used. This ensured that the whole endplate could be imaged whilst 
removing most of the unnecessary surroundings. This large magnification ensured that most of 
the structural features of the endplates were well within view. An interval thickness of 0.7µm 
was used. This was the maximum thickness allowed which could be obtained as Z stacks would 
overlap at a greater thickness, losing axial resolution. The confocal pinhole was set at 1 Airy 
unit. These settings are summarised in Table 2.2. For each experiment each channel was 
excited by a specific laser line of a distinct wavelength   
Each endplate and channel was imaged at the optimal settings for gain, offset and laser power. 
This was performed as outlined; 
(i) An endplate was located and identified according the pre-determined criteria stated in 
section 2.5.1 
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(ii) Using the AChR channel, I focused on the receptor endplate staining until the endplate 
was in clear view 
(iii) I then adjusted the gain settings using the pseudocolour setting until only a sprinkle of 
pixels were supramaximal (256 on the greyscale image) 
(iv) The offset was adjusted by eliminating as much noise as possible, while retaining as 
much of the endplate as possible. 
(v) I then switched to the next channel and adjusted the gain and offset settings similarly 
to the AChR channel. 
(vi) These steps are then repeated for the next endplate imaged 
 This ensured that each image was detailed and of good quality. This was necessary as 
endplates varied greatly in intensity, especially in the aged mice. However, this prevents 
comparison of staining intensity between endplates because gain settings need to be changed 
for each individual endplate. Approximately 20 endplates were obtained from each 
experimental animal.  Z stack projections were then obtained from endplates in the order 
described. The top and bottom sections of the scan were determined as the first scan that did 
not contain any of the image. The number of optical sections per endplate was determined by 
the software according to the thickness of the endplate. The images were saved as a LIF file to 
be quantified. 
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 Table 2.2. Confocal Microscopy Settings for Imaging endplates 
 
 
 
 
 
 
 
 
 
Settings En-Face Imaging Cross-Sectional Imaging 
Resolution 1024 x 1024 1024 x 1024 
Objective 63x oil immersion 40x oil immersion 
Pinhole 1 Airy Unit 1 Airy Unit 
Scan Speed 600Hz 600Hz 
Averaging 4 2 
Z-stack Thickness 0.7μm Single optical section 
Gain and offset Optimised for each 
individual endplate image 
Optimised for control /wild-
type endplates and then not 
changed throughout the 
imaging session 
Zoom factor 2x 1.5x 
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Table 2.3. Corresponding wavelength and Band pass filter for each Fluorophor 
Fluorophor Laser line Wavelength Band Pass Filter 
Alexa-555-α-bungarotoxin 555nm Rhodamine (530-550nm) 
Alexa-647-α-bungarotoxin 647nm Cy5 (663-738nm) 
Cy3 488nm FITC (460-490nm) 
FITC 488nm FITC (460-490nm) 
 
2.5.1 Sampling rules for En Face endplate imaging 
Several sampling rules had to put in place to ensure that the endplates I imaged were 
representative of the respective treatment groups.  
 
1. Imaging was conducted blind. Prior to each imaging session, the slides to be imaged were 
coded by a lab member not involved in the experiment. This was usually master’s student Nigel 
Tse or Honours student Joshua Way. The codes were recorded on a spreadsheet and were only 
revealed to me once the analyses of all the endplates from the imaging experiment were 
complete. The elevated MuSK-GFP experiment was an exception. It was not coded or 
performed blind because MuSK-GFP it was obvious during the imaging session whether an 
endplate was expressing MuSK-GFP (experimental group). This prevented me from performing 
the experiment blind.  
 
2. An endplate was defined as any region stained with rhodamine- alpha-bungarotoxin on 
AChR clusters that was enface to the objective and flat. An endplate was considered ‘enface’ 
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and was included provided it was less than 15 microns in Z-depth. This was the sole criteria in 
determining whether an endplate was enface. I determined the upper and lower extent of 
endplate AChR staining by manually focusing up and down. This allowed the Leica software to 
determine the Z-depth of the endplate. I ensured that the entire endplate was included in the 
subsequent z-stack. Experiments testing the impact of MuSK-GFP, were an exception to this 
rule in that not all ‘enface’ endplates were sampled. To examine the impact of MuSK-GFP only 
those endplates that had taken up MuSK-GFP were imaged.  
3. To prevent bias and potential repeated imaging of the same endplate, each section was 
scanned in a standard pattern. Each microscope field was examined in sequence from left to 
right, then in a non-overlapping scan from right to left (raster fashion). This method also 
minimised the risk of missing endplates that had to be analysed.  I continued this scanning 
until I had collected a total of 20 endplate images from each sample. 
 
 
2.6 Analysis of EnFace Images  
ImageJ software (http://imagej.nih.gov/ij/) was used for image analysis. The enface endplate 
structure allowed the following parameters to be assessed: 
 1) Area of AChR clusters  
2) Fragmentation of AChR clusters 
3) Anti-synaptophysin stained nerve area  
4) Co-localisation (percentage of AChR clusters covered by nerve).  
 
Chapter Two: Methods  
55 
 
First a maximum intensity z-projection image was created for each endplate by making a 
layered stack of optical slices. This z-projection image was subsequently used for analysis. 
Several settings had to be adjusted in the ImageJ software prior to analysis. Area 
measurements were made by intensity thresholding. This was done by clicking Analyse  Set 
Measurements  Ticking the box marked ‘Limit to threshold’. Also, the scale used by ImageJ is 
removed and units are converted to pixels. This was later converted back to square microns 
more accurately using our own calculated scale. For the 63x oil objective the conversion scale 
was 1 pixel2 = 0.00731 µm2. I removed the scale by clicking Analyse  set scale  select the 
box marked ‘global’  click to remove scale.   The co-localisation plug-in is required (it was 
downloaded directly from the ImageJ website). 
 
2.6.1 Area measurements of En-Face Images of the Neuromuscular Junction 
Accurate area measurements were obtained from en-face images using ImageJ software 
(Version 1.49) as follows.  
(i) The saved image .LIF file from the confocal session was transferred onto the lab PC 
and the file was opened in ImageJ. The AChR channel was opened first and the 
polygon tool selected. A rough outline is drawn around the AChR receptor-positive 
area, to include all regions of the endplate 
(ii) The image is then converted to a greyscale 8 bit image from a 24 bit RGB colour 
image.  
(iii) A minimum intensity threshold is then applied by selecting image  adjust 
Threshold. The threshold is adjusted so as to include the entire endplate while 
excluding as much noise or background fluorescence as possible. A second window 
of the same image may be opened to facilitate comparison during thresholding. 
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Area is measured by analyse  measure. The AChR area value is shown in pixels in 
the results window.  
(iv) The threshold value was then recorded in the excel spreadsheet for later use in co-
localisation analysis.  
(v) The next channel (nerve terminal) is selected on the ImageJ software, retaining the 
polygon outline. Here, the endplate is similarly thresholded as with the AChR 
receptor (step (iii)). As much of the endplate is included in the thresholded value 
that is possible, while excluding background noise.  
(vi) The threshold nerve area value is recorded in the spreadsheet for later use in co-
localisation calculations.  
(vii) The areas of AChR and synaptophysin are subsequently converted to square 
microns using the 63x oil objective \ conversion scale: 1 pixel2 = 0.00731µm2. 
 
2.6.2 Measurement of AChR Fragmentation at the endplate 
Number of AChR fragments per en-face endplate was obtained from ImageJ. After determining 
area measurements of AChR, the receptor cluster is also analysed for fragment count. Here, 
the threshold value used to determine AChR area is retained. The polygon outline is also 
retained from previous analysis. The command analyseanalyse particle results in the 
opening of a pop up window. Here the range of particle sizes was selected as 50-infinity pixels. 
This allowed us to exclude tiny units arising from noise. Analyse Measure records the 
number of fragments present at the AChR.  
2.6.3 Measurement of the Area of Overlap 
The image file is opened and separated into discrete images based on channel. This is done by 
the command Imagestacksstack to images. Here I selected the co-localisation plugin by 
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PluginCo-localisation. The threshold values recorded from the area measurements of AChR 
and Nerve are inserted into the respective boxes. This results in an overlap image which is 
converted to greyscale ImageType8-bit. This image is set to maximum threshold, which 
only selects for supramaximal synaptophysin-stained pixels that overlapped with AChR 
staining. The resulting overlap area in pixels was converted to square microns using the 
conversion factor given in section 2.6.1(vii).  This value was recorded in the spreadsheet.  
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2.7 Determining sample size for endplates in cross-section single 
optical section images 
For assessing relative staining intensity, single optical sections were used. To assess the 
appropriate endplate sample size needed to obtain a representative mean value I conducted a 
pilot experiment. The intensity neuromuscular junctions, specifically AChR and nerve, were 
compared between aged and young animals. Cumulative average of AChR and nerve 
intensities was plotted from an 8 week animal and 25 month animal, refer to Figure 2.1. The 
cumulative average plot revealed that a minimum endplate number of 50 were required for 
our cross-sectional experiments.  
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Figure 2.1 Cumulative averages for Endplate staining intensity 
 
 
Figure 2.1 Influence of endplate sample size upon average endplate staining intensity in 
single optical cross sections of endplates. (A) Average AChR staining intensity for endplates of 
8 month old mice. Plot has levelled out by 40 endplates. (B) Cumulative average for 25 month 
AChR intensity. Plot is levelling out by 40 endplates. (C) Cumulative average for 8 month nerve 
intensity.  Plot is levelling out by 40 endplates. (D) Cumulative average for 25 month nerve 
intensity. Plot has roughly levelled out  
  
A B 
C D 
Chapter Two: Methods  
60 
 
 
2.8 Confocal settings for transverse (cross-sectional) imaging of 
Endplates 
The Leica SpeII confocal microscope, was also used to obtain single optical images of endplates 
in cross-section. Such images could be collected rapidly allowing the relative staining intensity 
or many endplates to be compared in a single imaging session.  
 
Sampling rules for transverse optical section images: 
(i). To minimise subjective bias, again each slide was coded prior to imaging (ii) A 40x oil 
objective was selected to allow for imaging of several endplates in a single image. Again, a 
resolution of 1024 x 1024 and a scan speed of 600Hz were used to produce publishable quality 
images. A scan average of 4 was found to be adequate. A zoom factor of 1.5x was used as this 
was the minimum zoom required to produce accurate images. The images were found to bend 
at the edges at zoom factors less than this, producing unreliable data from endplates located 
there.  
(iii) At the start of each imaging session each fluorophor was allocated a laser of a distinct 
wavelength (table 2.3). Gain, offset and laser power were set at the outset and held constant 
throughout the experiment to facilitate intensity measurements. These gain and offset settings 
were determined as an approximate average of the settings from the control or non-treatment 
group. Since all slides were blinded prior to the imaging stage, setting of the gain and offset 
had to be conducted by someone not involved with the experiment (Nigel Tse).  
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(iv) Any crescent shaped rhodamine-α- bungarotoxin-stained structure was considered to be 
an endplate for inclusion in quantitation. Approximately 50 endplates per animal was 
obtained. This was determined from the results of a pilot experiment (see section_2.7).  
(v) To reduce bias each section was scanned in raster fashion (from the top left to the bottom 
right). The scanning was conducted on the bungarotoxin channel to identify all fields 
containing at least one crescent-shaped endplate.  
(vi) The AChR channel was and imaged first after fine focusing to maximise the number of 
crescent-shaped endplates per field (two averaged scans at 600 HZ scanning speed). 
(vii)  After imaging the AChRs I switched to the second fluorescence channel which was imaged 
without changing the focal plane. 
(viii) Images were saved as a LIF file for quantification. A typical file name would be 
150315EFagrin#1_ where the first six numbers indicate the date while the next two letters 
represent whether the images were taken en-face or as cross-sections and the rest indicate 
the experiment name followed by the imaging session. The file was then transferred to the 
PhillipsLab server and a backup copy saved on desktop and a separate hard drive. Confocal 
microscopy settings are listed in table 2.2. 
 
2.9 Analysis of Cross-Sectional endplate Images 
ImageJ software was used for analysis of cross-sectional images. The following parameters 
were assessed 1) AChR area 2) AChR staining intensity 
3) Co-distributed synaptophysin or rapsyn staining intensity, 4) endplate density.  
 
The analysis was conducted as follows: 
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(i) Single optical image (.LIF) files were opened in ImageJ. ImageJ was setup as 
described in section 2.6.  
(ii) Thresholding was used to define the stained areas. This was done by clicking 
Analyse  Set Measurements  Ticking the box marked ‘Limit to threshold’.  
(iii) The scale used by ImageJ is removed and units are converted to pixels. The scale is 
now converted to square microns more accurately using our own calculated scale, 
which for a 40x oil objective was 1 pixel2=0.03 µm2.  
(iv) Images were then analysed as described in sections 2.9.1 and 2.9.3 
 
 
2.9.1 Measurement of Post-Synaptic Area and endplate intensities in Cross-Sectional 
Images of the Neuromuscular Junctions. 
Cross-sectional AChR area was also measured between treatment groups. We developed the 
‘Masked method’ to ensure that only the regions overlying the AChR are measured for nerve 
and rapsyn intensity. This includes the area threshold and selected for in the AChR channel and 
applies it the nerve or rapsyn channel. This was important as in some images it was difficult to 
threshold nerve or rapsyn staining accurately due to background noise. This ensured that we 
were only measuring the intensity of the protein of interest (synaptophysin or rapsyn). The .LIF 
image file is opened using ImageJ software. The limit to threshold setting is selected and the 
scale bar is removed as in 2.7. Here, a close outline around the crescent shaped AChR is drawn 
using the polygon tool. The endplate may be zoomed in on using the ‘+’ key to ensure polygon 
outline is accurate. The image is converted to an 8 bit image. The AChR is then thresholded. 
The entire endplate is included; while most of the background noise is excluded (i.e. at sub 
threshold).The same image is opened in another window to facilitate comparison. The 
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thresholded value is recorded in the spreadsheet. The thresholded area is then measured. The 
value in the ‘area’ column is the thresholded area in pixels and the value in the ‘mean’ column 
is the intensity in pixels. The thresholded area within the polygon outline is then added to the 
ROI manager (This is done by selecting the ‘T’ shortcut. An outline of all receptor areas is then 
also selected and added to the ROI manager. Select editSelectioncreate selection ‘T’ to 
add this new selection to ROI manager. Using ROI manager, highlight the two 
outlines/selections that have been saved. Now right click the highlighted images select 
‘AND’. Only the endplate that has been previously selected with the polygon tool will show up 
with an outline. The nerve or rapsyn channel can now be measured for intensity. The nerve or 
rapsyn channel is selected and converted to 8-bit and the intensity is measured and recorded.  
 
2.9.2 Endplate Density Measurements 
This involved counting the number of bungarotoxin stained AChR endplates per microscope 
field in single optical sections. Microscope fields where no endplates were observed were not 
imaged. AChR clusters are progressively counted in each image and recorded in the 
spreadsheet. 
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2.10 Study of the NMJ in MuSK elevated animals 
2.10 Injections of adeno-associated viral vector  
MuSK levels were experimentally elevated in the mouse TA muscle by intramuscular injection 
of adeno-associated viral vector (rAAV) encoding MuSK-GFP. Six mice were aged and 
monitored at the Bosch animal house for this experiment. The injections were performed by 
Dr Sofie Trajanovska. In brief: 
(i) Mice were anaesthetized with 1-3% isofluorane via a facemask until the foot 
withdrawal reflex was suppressed 
(ii) The hair surround the hind limb was removed and an incision was made to expose 
the lateral surface of the TA muscle. 
(iii) 2x10^9 viral genomes of rAAV encoding MuSK-GFP rAAV (in 10μl saline solution) 
was injected into the belly of the left TA the left TA with a Hamilton syringe 
(iv) The right TA was similarly injected with 2x10^9 empty rAAV in 10μl saline solution.  
(v) The incisions were sutured and an intraperitoneal injection of analgesic 
buprenorphine was given.  
(vi) Mice were then held in the PC2 area of the Bosch animal house at the University of 
Sydney and were regularly monitored post-injection by either Dr Sofie Trajanovska 
or A/Prof Bill Phillips. 
 
2.11 Processing of MuSK-GFP Muscles  
Mice injected with rAAV were sacrificed and the TA muscles dissected by Dr Sofie Trajanovska 
after completing force contraction measurements on the muscles. The TA muscles were fixed 
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by immersion in 4% paraformaldehyde for 30 minutes, then were washed, cryoprotected in 
sucrose and frozen as described in section 2.4. Samples in clearly labelled Eppendorf tubes 
were stored in -80 C freezers until sectioning. Longitudinal sections were processed and 
stained as described in section 2.4 and Tse et al (2014) except for the use of alternative 
antibodies (Table 2.1).  
 
Cryosections of these muscles were imaged using three discrete channels emitting light at a 
specific wavelength (Table 2.3) MuSK-GFP emitted light at the 488nm wavelength, preventing 
the use of FITC as a secondary antibody to anti-synaptophysin. The secondary antibodies that 
were used in this experiment are described in table 2.1. Longitudinal images were obtained 
and parameters analysed as described in sections 2.5, 2.6 and Tse et 2014. However, only 
endplates that were shown to be expressing MuSK-GFP in the MuSK-GFP muscle were included 
in the analysis. The first 20 endplates imaged in the empty vector muscle were all included in 
the analysis. Parameters assessed were AChR area, Nerve area, percentage of overlap of nerve 
on AChR.   
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2.13 Analysis of the NMJ in L25 Line Mice 
 
2.13.1 The L25 mouse line 
The L25 transgenic mouse line was created via a random sef transgene insertion by Professor 
Frank Lovicu at the University of Sydney (Newitt et al., 2010).Progeny of L25+/- x 
L25+/- matings were monitored and characterized as either affected (spastic paralysis) 
or unaffected wild-type by honours student, Eva Kichkin in the Gunn animal facility at 
the University of Sydney in 2014. Mice were provided with food chow and water ad 
libitum. Each cage had paper tissues, a plastic igloo and a cardboard roll to allow for 
environmental enrichment. Temperature and lighting were maintained at 21 C and a 
12 hour light-dark cycle.  
Mating of L25 Heterozygous mice resulted in approximately a quarter of the L25 progeny being 
identified as affected. PCR tests, from tail clip samples, were conducted to identify wild type 
L25 -/- from affected L25 +/- or +/+ mice (Honours thesis, Eva Kichkin 2014).  Each mouse was 
identified by an earmark code (ear punch) established at two weeks of age. Mice were 
weighed weekly initially. As mice approached their endpoint, frequency was increased to daily 
weighing.  
At three weeks of age, mice were monitored carefully for motor signs of body tremor and hind 
leg retraction when held by the tail. Mice that were exhibiting these symptoms were classed as 
affected. Beginning at 5 weeks of age, weekly behavioural testing was monitored by open field 
testing and righting reflex tests. The open field consisted of a clear Perspex box with the base 
divided into 15 marked squares. The mouse was free to roam for 1 minute. The animal was 
then suspended by the tail for 5 seconds, while behaviour was recorded. Body tremor and hind 
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limb retraction was especially noted. After behavioural tests animals were tested for loss of 
righting reflex. The mouse was flipped on its back and observed whether it could correct its 
posture and regain its feet within ten seconds.  
Mice were sacrificed at the endpoint. The endpoint was defined as the point where the mouse 
lost 15% of its peak body weight or developed a weakness grading of II. Grade II weakness is 
defined as 1 minute of inactivity when placed in the centre of a table or the loss of the righting 
reflex. Perfusion of the animal was conducted on the day the animal reached its endpoint and 
its unaffected littermate control. The animals were anaesthetised with 4% isofluorane in 
oxygen until loss of consciousness. The mouse was subsequently sacrificed by administering an 
intraperitoneal pentobarbitone injection (30mg/kg).  The mice were perfused transcardially 
with saline followed by 4% paraformaldahyde in PBS. Spinal cord, brain and TA were dissected. 
The TA muscles were washed in 0.01M PBS to remove excess PFA. The TA muscles were then 
transferred to a solution consisting of 30% sucrose and 0.05% sodium azide in PBS. In total 
there were 6 affected L25 mice that had reached their endpoint and 6 unaffected littermate 
controls. All six pairs were included in this experiment. 
I then dissected and froze the perfusion-fixed TA samples using techniques as previously 
described in this chapter. Using techniques previously described in this chapter 
(cryosectioning, immunohistochemical staining and confocal techniques) I obtained good 
quality en-face images of endplates from L25 affected and wild-type control mice. Parameters 
analysed were AChR area, Nerve area, endplate density and percentage of nerve overlap over 
AChR.
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3.1 Introduction 
Mouse embryos lacking a functional copy of either the agrin or rapsyn gene do not 
develop functioning NMJs and die around the time of birth (Gautam et al., 1996; 
Gautam et al., 1995). Mice with a single copy of either the agrin or rapsyn gene (agrin 
+/- or rapsyn +/- mice) are viable but the effect of this reduced gene dosage upon the 
size of the adult NMJ has not been studied quantitatively. Here I measure the size and 
alignment of adult and aging neuromuscular junction, comparing heterozygous mice 
(+/-) with wild-type mice C57B16J mice.  
This chapter includes experiments to test the hypothesis that reduced gene agrin and 
rapsyn gene dosage will affect the size of the NMJ, in particular the pre-synaptic 
and/or post-synaptic regions. Based on past research showing age associated 
impairment at the NMJ(Cheng et al., 2013) and importance of the MuSK system in 
maintenance of the NMJ (Sanes & Lichtman, 2001) , we hypothesised that a reduction 
in agrin or rapsyn gene dosage would prematurely reveal age-associated changes 
and/or exacerbate these changes to the NMJ.   
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3.2 Experimental animals used in this study 
To investigate the effect of gene dosage for agrin or rapsyn on age-related changes in NMJ 
structure I compared a limited number of available aged heterozygous mice and wild-type 
mice that were ex-breeders from the colonies of Dr Peter Noakes at University of Queensland. 
Table 3.1 lists the mice I was able to study. The numbers of mice were limited to female ex-
breeders. Since elderly mice can harbour tumours or chronic diseases that might distort 
findings, mice that displayed abdominal tumours or markedly enlarged spleen/body weight 
ratio were excluded from this study.  
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Table 3.1 Rapsyn+/-, Agrin+/- and Wild type mice studied 
Mouse Code Genotype Age (months) Body weight 
(g) 
Spleen 
weight (g) 
Spleen/Body 
weight ratio 
Q9-13-48 Rapsyn +/- 11 36.7 0.16 0.0044 
Q1-2-45 Rapsyn +/- 12 31 0.135 0.0044 
Q9-9-33 Rapsyn +/- 15 42.2 0.122 0.0029 
Q3-8-56 Wild Type 11 28.8 0.124 0.0043 
Q3-8-57 Wild Type 11 25.1 0.107 0.0043 
#256 Wild Type 14 32.3 0.09 0.0027 
#255 Wild Type 14 28.8 0.12 0.0041 
#133 Wild Type 22 31 0.1207 0.00389355 
#131 Wild Type 22 29.9 0.1437 0.00480602  
#138 Wild Type 22 31.3 0.1739 0.00555591 
#127 Wild Type 19 25.3 0.123 0.00486166 
#129 Wild Type 22 33.7 0.1462 0.00433828 
#137 Wild type 22 29.9 0.1247 0.00417057 
Q13-2-65 Agrin +/- 21 41 0.144 0.0035 
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Q19-4-56 Agrin +/- 21 40.7 0.252 0.0062 
Q19-4-58 Agrin +/- 21 34.4 0.096 0.0028 
Q13-4-56 Agrin +/- 19 47.4 0.254 0.0054 
 
 
  
 
3.3 Comparison of NMJs in agrin+/- versus +/+ mice 
3.3.1 Comparison of the density of pre- and postsynaptic markers in agrin+/- versus +/+ mice  
Transverse optical sections through the endplate facilitate comparison of the relative 
density of proteins in the pre- and postsynaptic specializations (see Methods; Tse et al. 
2014). Transverse cryosections of the tibialis anterior (TA) muscle were obtained from 
agrin +/- mice and naive healthy mice as controls, aged 21 months and 22 months 
respectively. These mice were subsequently double labelled for pre-synaptic nerve 
terminals, using anti-synaptophysin (with FITC secondary antibody) and for post-
synaptic AChR clusters (Alexa555-α-bungarotoxin). Single confocal optical images were 
collected as described in the Methods chapter. Figure 3.1 exhibits examples of 
transverse optical images of agrin +/- NMJ compared with agrin +/+ NMJ. In these 
images the most intense fluorescence staining is represented by the darkest areas. Fig 
3.1A displays crescent shaped postsynaptic AChR clusters as they typically appear in 
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wild-type (agrin+/+) mice. Fig 3.1B shows that pre-synaptic synaptophysin staining lay 
immediately above each postsynaptic AChR 'crescent' from the naive healthy +/+ mice. 
Figures 3.1C & D displays a comparable microscope field but from an agrin+/- mouse. 
Similar crescent shaped endplate AChR clusters are observed (Fig 3.1C) and are 
innervated by synaptophysin-stained nerve terminals, similar to wild-type (Fig 3.1D).  
The area occupied by the postsynaptic AChR crescent was measured for 311 wild-type 
and 213 +/-endplates (from three mice). The distribution of ACHR areas was roughly 
Gaussian (Fig 3.2A), with no difference in the mean area between agrin+/- and +/+ 
mice (Fig 3.2B; unpaired t test P=0.9091 n=3 mice). The mean fluorescence intensity of 
endplate AChR staining was also normally distributed, data represented with 311 agrin 
+/+ and 212 +/- endplates (Fig 3.3A) with no significant difference in the mean pixel 
intensity (Fig 3.3B; P=0.7386; n=3 mice). Similarly there was no significant difference in 
the relative intensity of anti-synaptophysin staining when comparing agrin+/- mice 
with agrin+/+ mice (Fig 3.4; P= 0.7471). 
 
Conceivably, the reduced gene dosage might result in fewer NMJs being formed or 
maintained per muscle. Such a difference might be revealed by a lower density of 
NMJs per microscope field. However, counts revealed no difference in endplate 
density when comparing agrin +/- and agrin+/+ mice (Fig 3.4; P=0.7386). 
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The mean fluorescence intensity of endplate synaptophysin staining was measured for 
311 agrin +/+ endplates and 212 agrin +/- endplates from n=3 mice (Fig 3.5A) with no 
significant difference in the mean pixel intensity (Fig 3.5B; P=0.7386 n=3 mice).  
 
These results obtained from transverse optical sections seem to provide no support for 
the hypothesis that reduced agrin gene dosage affects the size of the aging mouse 
NMJ, the densities of synaptic vesicles (nerve terminal) and postsynaptic AChR density. 
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3.3.2 Comparison of the area of pre- and postsynaptic specialisations in agrin+/- versus +/+ 
mice. 
Enface images, constructed from longitudinal optical sections show the full extent of the 
endplate, rather than a random cross section through it. They can provide a more sensitive 
measure of possible differences in NMJ area and synaptic alignment (Tse et al. 2014). 
Longitudinal cryosections of the TA muscles (20um) from four agrin +/+ mice and four agrin +/- 
mice were stained for nerve terminal synaptophysin and post-synaptic AChR clusters, as 
described in methods. Confocal microscopy was used to acquire high quality z-stack maximum-
projection images of pre-synaptic and post-synaptic regions. These enface images allowed 
measurement of AChR area, nerve area, AChR fragmentation and the area of alignment of 
synaptophysin-rich nerve terminal over postsynaptic AChR. Since the gain and offset levels 
were optimised for each NMJ, staining intensities cannot be compared. 
Figure 3.6A shows an example en face image of an endplate from a 22 month old agrin+/+ 
mouse labelled with α-bungarotoxin staining the AChR. The postsynaptic AChR plaque 
displays several branches and some smaller ACHR clusters that are disconnected from 
the main plaque. Anti-synaptophysin labelling of the same NMJ shows a substantial but 
imperfect nerve terminal alignment over the postsynaptic AChRs (Fig 3.6B). Similar 
pretzel shaped AChRs can be seen in both images. Note the relatively dim anti-
synaptophysin staining of the aging nerve terminals, in both agrin +/+ and agrin +/- 
endplates,  consistent with previous findings in elderly mice (Cheng et al., 2013; Tse et 
al., 2014). Figures 3.6C&D show comparable images from a NMJ of a 21 month old 
agrin +/- mouse. 
Chapter 3. Results: Effect of reduced rapsyn and agrin gene-dosage on structure of the NMJ  
81 
 
Quantitation of the area of AChRs per endplate (viewed en face) is shown in Fig 3.7. 
Once again the areas of endplates were normally distributed (Fig 3.7A). Contrary to my 
hypothesis, the measurements from enface images again revealed no difference in 
AChR area (Fig 3.7; P=0.8830; n=4).  
Data concerning area occupied by the nerve terminal is shown in Fig 3.8. Figure 3.8A 
shows a frequency distribution of synaptophysin-positive nerve terminal area over 
endplates from 86 agrin +/+ and 73 agrin +/- endplates (from n=4 mice). No significant 
difference was observed (Fig 3.8b; P=0.8957). 
 
Fragmentation of the endplate AChR plaque is a common feature of aged and 
damaged endplates. Therefore, we analysed the number of AChR cluster fragments 
per endplate, comparing agrin +/+ and +/- mice. Fig 3.9a represents an interleaved 
frequency distribution representing the number of AChR fragments present per 
endplate (86 agrin +/+ and 73 +/- endplates pooled from n=4 mice). Both genotypes 
showed a somewhat skewed distribution with a fraction of endplates showing >5 AChR 
cluster fragments. However there was no obvious difference in the shape of the 
distribution and no significant difference in the mean number of AChR cluster 
fragments per endplate between agrin+/+ and +/- mice (Fig 3.9b; P=0.7722). 
 
Finally I measured the degree to which endplate AChRs were covered by 
synaptophysin-positive nerve terminals (Fig 3.10). Percentage overlap was measured 
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by dividing the synaptophysin area by AChR area and multiplying by 100. Fig3.10a is a 
roughly Gaussian distributed frequency histogram representing data from overlap of 
75 agrin +/+ and 77 agrin +/- endplates. No significant difference was observed (Fig 
3.10b, P=0.9784). This result suggests that for 21-22-month old mice reduced agrin 
gene dosage did not affect the degree to which the endplate remained innervated.  
These results from longitudinal z-stacks do not seem to support the hypothesis that 
reduced agrin gene dosage affects the size of the ageing mouse NMJ, synaptic vesicle 
density and postsynaptic AChR density. 
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3.4 Comparison of NMJs in rapsyn+/- and +/+ mice 
In previous studies in young mice muscles of rapsyn+/- mice expressed significantly 
lower concentrations of total rapsyn, when compared to age-matched wild-type mice 
and this was associated with retarded postnatal development of the endplates 
(Brockhausen et al., 2008). Here I examined the possibility that reduced rapsyn gene 
dosage (rapsyn+/- mice) might exacerbate age-associated impairments to NMJs.  
I used transverse optical sections of the TA muscle to compare the intensity of 
endplate AChR and rapsyn staining in 11-15 month old rapsyn+/+ and +/- mice (n= 3 
mice). Rapsyn was stained by direct immunofluorescence using anti-rapsyn 
monoclonal antibody 1234 (directly conjugated to FITC). Fig 3.11 shows endplates in 
sample sections from rapsyn +/+ and +/- muscles. Quantitation of the average pixel 
intensity of the crescent shaped endplates revealed a wide range of rapsyn staining 
intensities among endplates of these aging mice, but there was no difference between 
+/+ and +/- mice in the mean anti-rapsyn staining intensity (Fig 3.12; P=0.2056) . 
Although no statistical difference was observed a trend was observed towards lower 
intensity of rapsyn +/- mice when compared to rapsyn +/+ group. Increased sample 
size may yield a significant result. ACHR staining intensity was normally distributed (Fig 
3.13A). There was a trend for endplates of rapsyn+/- mice to stain less intensity than 
endplates of rapsyn+/+ muscles but the difference in the mean did not reach statistical 
significance (Fig 3:13B; P=0.4645). The mean area of the AChR-stained endplate 
crescents was not significantly different in rapsyn +/+ and +/- mice (Fig 3.13; 
P=0.4431).  
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In early postnatal mice, rapsyn+/- mice endplates of the tibialis anterior muscle 
displayed significantly lower rapsyn/AChR fluorescence intensity ratios and relatively 
lower AChR staining intensities compared to rapsyn+/+ mice (Brockhausen et al 2007).  
This was not true in the 11-15 month old mice that I examined. Endplates of elderly 
rapsyn+/- mice revealed a trend toward reduced rapsyn/AChR staining intensity ratio, 
but this trend did not reach statistical significance (Fig 3.14; P=0.1280 respectively). In 
the elderly mice there was no difference in the AChR staining intensity between rapsyn 
+/+ and +/- mice (Fig 3.15; P=0.1130). Endplate density comparisons did not reveal any 
differences between rapsyn +/+ and +/- mice (Fig 3.16; P= 0.2406 n=3).  These results 
suggest that, as mice age, the density of rapsyn in the motor endplate becomes 
independent of gene dosage.  
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3.5 Conclusions 
Experimental results seem to suggest that reduced agrin or rapsyn gene dosage has no 
effect on the structural integrity of the neuromuscular junction. No statistical 
difference was observed in the pre-synaptic or post-synaptic regions studied between 
agrin and rapsyn +/+ and +/- mice.  This suggests that the parameters assessed are 
independent of agrin or rapsyn gene dosage for structural intensity. 
The experiment was limited by use of small sample sizes. A limited number of agrin 
and rapsyn +/- animals of similar ages were available. Increasing sample size may yield 
a more confident result of reduced gene dosage comparisons.  
A lack of a full range of ages prevented a study of the NMJ at reduced agrin or rapsyn 
gene dosage at different ages. The lack of available mice of a range of ages limited the 
study to aged animals. This prevented study on NMJ development or age differences of 
NMJ structural integrity in mice with reduced dosage of rapsyn or agrin. 
The lack of an agrin antibody prevented the measurement of agrin gene dosage in the 
mice. The possibility exists that agrin gene dosage was not reduced in the agrin +/- 
mice. To increase confidence in the results it would be suitable to determine the levels 
of agrin gene dosage in both the agrin +/+ and +/- mice. 
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Chapter 4. Results: The Influence of Elevated MuSK Expression on 
the Ageing Neuromuscular Junction 
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In this chapter I investigated the effects of experimentally elevating muscle levels of 
MuSK expression upon the neuromuscular junction (NMJ) in aging mice. Several 
structural impairments are associated with the aged NMJ such as decreased AChR and 
nerve area, increased AChR fragmentation, withdrawal of the nerve terminal and 
reduced percentage overlap of nerve over AChR (Cheng et al., 2013). These age-
associated synaptic changes may result in decreased effectiveness of neuromuscular 
synaptic transmission and subsequent decline in muscular performance (Cheng et al., 
2013; Faulkner et al., 2007). Given the central role of MuSK in development of the 
NMJ, tested whether over-expressing recombinant MuSK via an adeno-associated viral 
vector can ameliorate some of these age associated change to the structure of the 
NMJ. In this regard, elevated expression of a MuSK transgene has previously been 
shown to ameliorate denervation and some aspects of muscle weakness in a mouse 
model of amyotrophic lateral sclerosis (Perez-Garcia & Burden, 2012).  
 
4.1 Experimental Mice used in this Study 
Table 4.1 lists experimental mice used in the Elevated MuSK expression study. All mice were 
C57B16J and were 25 months of age when culled. Mice were housed, injected with rAAV or 
empty vector and housed as described in methods chapter. My study of the protective effect 
of elevated MuSK expression during ageing was limited by the number of mice that survived to 
old age and sufficiently expressed MuSK-GFP.  
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Table 4.1 Experimental Mice used in MuSK study 
Mouse Code Expressing MuSK-GFP* Age at which injected 
with rAAV (months) 
MuSK Sore Mouse Yes 22 
MuSK overexpressed#1 No 22 
MuSK overexpressed#2 Yes 22 
MuSK overexpressed#3 Yes 22 
MuSK overexpressed#4 No 22 
 
 * Indicates whether MuSK-GFP was observed in the muscle at all 
 MuSK sore mouse developed an open wound or ‘sore’ on its back and had to be 
euthanased approximately 3 days before the other animals. 
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4.2 Comparison of Elevated MuSK Expression to Empty Vector in Aged Mice 
Wild-type mice were injected in the left tibialis anterior (TA) muscle with adeno 
associated viral vector (rAAV) encoding MuSK fused to enhanced green fluorescent 
protein  (MuSK-GFP) under transcriptional control of a cytomegalovirus promoter so as 
to elevating MuSK expression above normal physiological levels. The contra-lateral TA 
muscle was injected with an empty rAAV vector as a control.  
After allowing 3 months for MuSK-GFP expression (Table 4.1), the mouse was killed by 
an overdose of pentobarbitone and both TA muscles were dissected.  Longitudinal 
muscle cryosections were obtained. These cryosections were subsequently stained for 
endplate AChR with (Alexa647-alpha bungarotoxin) and anti-synaptophysin followed 
by Cy3-labelled secondary antibody (to reveal synaptic vesicles). Confocal z-projections 
were obtained (described in Methods). 
Figure 4.1 displays sample images of endplates from muscle injected with empty 
vector compared with endplates from muscle injected with MuSK-GFP. Fig 4.1 (A-C) is 
a sample endplate from a 25 month muscle after injection of empty rAAV vector. 
Viewed in this way the pretzel shaped AChR cluster stained with 647 alpha 
bungarotoxin is seen to be largely covered by an anti-synaptophysin-stained nerve 
terminal).  A muscle fibre expressing MuSK-GFP also shows a pretzel shaped AChR 
cluster innervated by a synaptophysin stained nerve terminal (Fig 4.1C-E). 
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Approximately 40% of muscle fibres were found to express MuSK-GFP in muscles 
injected with rAAV-MuSK-GFP. In almost all fibres expressing MuSK-GFP, MuSK-GFP 
was found in extra-synaptic regions. 
Endplate Z-projections of the kind shown in Fig 4.1 facilitate quantitation of pre- and 
post-synaptic regions (Tse et al., 2014). The area of each endplate occupied by the 
AChR was measured for 58 NMJs from muscles injected with empty rAAV vector and 
67 MuSK-GFP-positive endplates. The distribution of AChR area displayed a roughly 
normal distribution (Fig 4.2A). No difference was found in the mean AChR area (Fig 
4.2B; P=0.8858). Nor was there any trend in the comparison between paired muscles 
of each mouse (Fig 4.2C). 
Synaptophysin-positive pre-synaptic nerve area was measured for the same set of 
endplates from MuSK-GFP-expressing and control muscle fibres. Data was normally 
distributed (Fig 4.3A). No significant difference was observed between the mean nerve 
terminal areas of MuSK-GFP-positive endplates and empty vector controls (Fig 4.3B, 
P=0.8519). ). No trend was observed in the comparison between paired muscles of 
each mouse (Fig 4.3C). 
If increased MuSK expression did protect against impairment changes at the endplate, 
then this might be reflected in a reduced (age-associated) fragmentation of the 
(pretzel-like) endplate AChR plaque. Data from the same group of MuSK-GFP positive 
and control fibres showed a slightly skewed normal distribution of AChR cluster 
fragments per endplate (Fig. 4.4A). Endplates expressing MuSK-GFP showed a slight 
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trend toward increased numbers of AChR cluster fragments (Fig 4.4A & C) but the 
difference in the mean was not statistically significant Fig 4.4B; P=0.2294). These 
finding provide no support for the idea that elevating MuSK expression prevents or 
reverses age-associated fragmentation of the endplate AChR plaque. 
Increased nerve and AChR alignment is a sign of NMJ stability. If elevated MuSK 
expression did protect at the endplate, then one might expect a higher level of 
alignment of nerve terminals over endplate AChRs. The percentage of endplate AChRs 
covered by synaptophysin-positive nerve terminal for individual endplates varied 
markedly was varied but roughly normally distributed (Fig 4.5A). No significant 
difference was found in the means between MuSK-GFP endplates and empty vector 
controls (Fig 4.5B; P=0.1532). No trend was observed between paired muscles of 
MuSK-GFP and empty vector endplates (Fig 4.5C) 
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4.3 Conclusions 
These results provide little support for the idea that elevated MuSK expression can 
protect the NMJ from previously described (Cheng et al., 2013) age-associated 
structural changes. Both control and MuSK elevated groups experienced quantitatively 
similar age-associated changes. 
This experiment was limited by the small sample size available. The sample size (n=3) 
was determined by the number of mice that survived to old age and sufficiently 
expressed MuSK-GFP.  This small sample size may not be indicative of a true significant 
result. Increasing the sample size may yield a significant result. 
Stability of MuSK-GFP in aged animals and length of time MuSK-GFP should be applied 
for, could be considered as areas for future study. Several muscle fibres, and 
sometimes entire muscles, showed no MuSK-GFP staining. Perhaps aged animals do 
not take up GFP as efficiently as younger animals and require either a longer or shorter 
timeframe to ensure a sufficient number of fibres over express MuSK.  A pilot 
experiment identifying the length of time MuSK over-expression needs to be applied in 
aged animals could be performed. 
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5.1 Introduction 
   The L25 line was generated by the random insertion of a transgene. The transgene 
concerned was sef, an antagonist of fibroblast growth factor signalling  under the 
transcriptional control of regulatory elements of the crystaline genes so that it was selectively 
expressed in the lens (Newitt et al., 2010). In the L25 line of mice a single copy of the Sef 
transgene (L25+/- mice) displayed altered lens development but other body systems appeared 
normal and mice were fully viable. However, when L25 heterozygous mice were bred (+/tg x 
+/tg) approximately one quarter of the progeny developed tremor and spasticity in their hind 
limbs (Eva Kichkin, Honours thesis 2014). The working hypothesis arising from these studies is 
that in the L25 line, the transgene by its chance insertion into the mouse genome  has 
disrupted a gene essential for motor function and L25 mice that inherit two copies of the 
disrupted gene undergo some form of degeneration of descending motor pathways. The onset 
of tremor and paralysis in the mice was reminiscent of mouse models for motor neuron 
disease raising the question of whether lower motor neurons controlling the hind limbs were 
affected. 
My hypothesis was that the transgene has disrupted the expression of a gene that affects 
neuronal function of the motor system by degeneration of motor neurons. In this chapter I 
investigate whether structural changes occur at the NMJ, especially motor endplate 
innervation, by performing paired comparisons of affected and non-affected animals.  
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5.2 Experimental Animals used in this Study 
The six affected mice and six paired control mice used in this chapter were progeny studied by 
Eva Kichkin in 2014. Critical to the study is the evidence that the affected mice were indeed 
affected. Table 5.1 lists the mice I was able to study.  Wild type control animals were 
determined by using PCR, identifying all animals that did not have the transgene (i.e. no band 
present). However, this did not allow us to identify transgenic mice that carried one alleic copy 
of the transgene (+/tg; heterozygous) from mice that contained two alleic copies of the 
transgene (tg/tg; homozygous). Affected animals were identified at approximately 3 weeks, 
where a subset of animals appeared to show a fine, sustained tremor and hind limb retraction 
when held by the tail. These symptoms have been described as a sign of motor dysfunction 
(Wils et al., 2010). These animals were classed as affected. 
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Table 5.1 Experimental Mice Used in L25 Study 
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5.3 Comparison of the Neuromuscular Junction in affected L25 mouse 
line to unaffected controls 
 
Enface z-projection images of endplates were again used, this time to compare NMJ structures 
in affected and non-affected mice  (Tse et al., 2014). Longitudinal sections of affected L25 mice 
and their unaffected controls were obtained from L25 affected mice and their unaffected pair. 
Most of the affected mice were killed 2-3 months of age due to serious motor problems as 
outlined in Table 5.1. Their paired control, a wild-type littermate was killed within one week so 
as to be roughly age-matched. The tibialis anterior (TA) muscles were dissected and stained for 
AChR and nerve terminal synaptophysin as described in the Methods chapter.  
Figure 5.1A&B shows a sample image of an NMJ from a 3-month old wild type L25 control 
mouse revealing the endplate AChR plaque and synaptophysin-stained nerve terminal 
respectively. The well-innervated pretzel-like structure is consistent with other healthy young 
NMJs (Tse et al 2014). Fig5.1C&D shows a sample NMJ from the affected L25 pair mouse. The 
endplate is also pretzel shaped and well innervated. The area occupied by AChR was estimated 
for 117 endplates from unaffected control mice and 120 endplates from affected L25 mice.  
AChR area per endplate was found to be normally distributed (Fig 5.2A). When the animal 
mean values were compared there was no significant difference in mean AChR area between 
affected and unaffected animals (Fig 5.2B, P=0.6471, n=6). Data comparing means of paired 
animals showed no obvious trend towards significance (Fig 5.2C). 
If the innervation of the motor endplate was altered in affected animals, then we might expect 
to see a reduction in average nerve terminal area. The area occupied by synaptophysin-stained 
nerve terminal was measured from the same samples of NMJs as above. Nerve terminal area 
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displayed a roughly normal distribution (Fig 5.3A). No significant difference was seen in mean 
nerve area between affected and unaffected L25 animals (5.3B, P=0.2526, n=6). However, one 
pair of animals was seen as outliers with much smaller NMJs (both pre and postsynaptic areas 
being very low) (Fig 5.3C). 
AChR fragmentation is a common feature of damaged and regenerated motor endplates. The 
number of AChR clusters per endplate was highly skewed towards small numbers of AChR 
clusters (Fig 5.4A). A Mann-Whitney test revealed that there was no apparent difference 
between the number of AChR clusters per endplate for affected and wild-type control mice 
(Fig 5.4B, P=0.8041, n=6). Again no obvious trend was observed in the mean fragment count of 
paired animals.  
Finally I considered the degree to which the endplate AChRs were covered by synaptophysin-
stained nerve terminal.  No significant difference was observed between the means of affected 
and unaffected animals (Fig5.5B, P=0.9156, n=6). No trend was evident when comparing the 
degree of innervation between paired animals was observed (Fig 5.5C). 
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5.4 Conclusions 
These results do not lend support to our hypothesis of lower motor neuron involvement in the 
symptoms of L25 mice. In addition, no alteration in motor neuron innervation was noted. 
These experiments were limited by the sample size of animals we could obtain. I was limited 
by the number of affected animals that were produced from breeding, were classed as 
affected and had a wild type control pair. Also, transgenic mice that carried one alleic copy of 
the transgene (+/tg; heterozygous) from mice that contained two alleic copies of the transgene 
(tg/tg; homozygous) were not differentiated by PCR.  Affected animals were determined by 
observations of motor symptoms. The determination of the endpoint may have affected the 
results of this study. It is possible that if we had allowed the severity of the motor symptoms to 
deteriorate further, we may have observed significant changes in lower motor neuron 
involvement.  
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6.1 Summary of Findings 
In this thesis I provide evidence contesting my initial hypotheses. Based on past literature, 
agrin, rapsyn and MuSK were found to be critical in the development and maintenance of the 
neuromuscular junction (NMJ) (DeChiara et al., 1996; Gautam et al., 1996; Gautam et al., 1995; 
Hesser, Henschel, & Witzemann, 2006). The failure to develop normal synapses results in 
death soon after birth, preventing study in aged animals. In addition, several structural 
impairments are observed in the elderly NMJ (Cheng et al., 2013), which result in impaired 
synaptic transmission and subsequent muscle contraction. Some cases of congenital 
myasthenia gravis are caused by inherited mutations to the rapsyn, DOK7 or MuSK genes 
(Lorenzoni, Scola, Kay, & Werneck, 2012). While the NMJ failure trait is recessive in these 
cases, it remains possible that the heterozygous carriers might be more prone to subliminal 
age-related NMJ impairments. To test my hypothesis that reduced gene dosage of agrin and 
rapsyn (major proteins of the MuSK system) would accelerate and exacerbate age associated 
changes of the NMJ, I examined several structural parameters of the NMJ in aging mice with 
only a single copy of the agrin or rapsyn gene. Surprisingly, I found no significant changes in 
NMJ structure between the heterozygous mice and wild-type mice with the full complement of 
agrin and rapsyn.   
6.1.1 Agrin 
The NMJs from agrin heterozygous mice were assessed for several parameters, namely AChR 
area, nerve area, synaptophysin staining intensity, fragmentation of the AChR-rich area and 
percentage overlap of the presynaptic nerve terminal over postsynaptic receptor area. I also 
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examined the density of NMJs within muscle sections as an indirect test for denervation. No 
significant changes were detected between treatment and control groups. These findings 
suggest that one copy of the agrin gene is sufficient for ensuring a normal NMJ structure in 
adult NMJs, with normal NMJ structures existing in the presence of low agrin gene dosage. It 
remains possible that agrin protein expression was not reduced in agrin heterozygous mice 
compared to wild-type mice. This caveat will be discussed in the section below. Another 
possibility is that agrin deficiency is only critical at the developing NMJ and both structural 
defects may only occur at early stages of NMJ development. However, this seems unlikely as 
the literature shows that although AChRs can still form in agrin deficient muscle, agrin is 
required later in development to counteract the Ach/Calpain pathway to prevent cluster 
dispersal (Kummer, Misgeld, & Sanes, 2006; Rudolf, Khan, Labeit, & Deschenes, 2014). 
Conceivably there might be a compensatory developmental mechanism whereby another 
pathway ensures a normal NMJ structure is maintained even in agrin-deficient muscle. Possible 
candidates for this compensatory pathway include the laminin-integrin (alpha-7) pathway and 
laminin-dystroglycan Ach receptor signalling pathways. Laminin is known to promote co-
localisation of integrins and AChRs and their subsequent aggregation into clusters. Agrin alone 
does not promote localisation of integrins with AChRs. Laminin has been shown to reduce the 
levels of agrin required to promote AChR clustering by 20 fold {Burkin, 2000}. Also, laminin and 
α-dystroglycan interact to promote AChR aggregation at the developing NMJ. It has been 
shown in C2 myotubes that laminin induces a twofold increase in AChR clustering, suggesting 
that laminin is involved in the growth or stabilisation of AChRs. In S27 cells, which lack a 
functional dystroglycan insert fail to aggregate AChRs in response to laminin, suggesting that 
both laminin and dystroglycan is essential in this pathway to cluster AChRs {Montanaro, 1998}.  
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Also, it is known that during ageing, fast twitch motor neurons are preferentially lost. The 
remaining slow twitch motor neurons re-innervate the previously de-nervated fast twitch 
fibres. The NMJ of slow twitch fibres are both functionally and structurally different to those of 
fast twitch fibres. Perhaps my results are indicative of this change and not changes of the 
MuSK pathway {Schiaffino, 2011}. These are possible compensatory pathways for reduced 
gene dosage of essential genes of the MuSK Pathway. Lack of access to a suitable agrin 
antibody prevented me testing whether that agrin protein expression levels were reduced in 
the heterozygotes. 
6.1.2 Rapsyn 
The NMJs from heterozygous rapsyn mice were assessed for AChR area, AChR intensity, rapsyn 
intensity, fragmentation of the AChR-rich area as well as the density of endplates. Again, no 
significant changes were observed between treatment and control groups.  The intensity of 
endplate immunostaining for rapsyn and the rapsyn: AChR ratio were not changed significantly 
in rapsyn +/- in comparison to the +/+ groups. This differs from a previous study in which the 
rapsyn: ACHR ratio was reduced at endplates of rapsyn+/- mice at 2 and 4 weeks postnatal, 
with associated differences in endplate ACHR packing (Brockhausen et al 2008). This suggests 
that either the rapsyn translation rate was not a limiting factor in supplying the aging 
endplates in heterozygous mice or that some posttranslational compensation may occur as the 
rapsyn heterozygotes grow to adulthood. As described earlier the laminin-integrin (alpha-7) 
pathway and laminin-dystroglycan Ach receptor signalling pathways may be possible 
compensatory pathways for reduced gene dosage. Also, gene dosage does not necessarily 
mean that protein levels are reduced. It remains possible that rapsyn protein expression was 
not reduced in rapsyn heterozygous mice compared to wild-type mice. Further tests such as 
PCR are required to confirm that gene dosage is reduced in rapsyn +/- groups.  In any event 
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one copy of the rapsyn gene was sufficient for ensuring a normal NMJ structure in adult NMJs. 
This is surprising as rapsyn mutations in humans are known to cause AChR deficiency and 
myasthenic syndrome (Ohno et al., 2002).  It may be possible that reduced rapsyn may only be 
critical at the development stage and may result in delayed development of the NMJ. Perhaps 
if NMJs were studied at a range of age groups this may reveal changes during development.  
En-face analysis may reveal a reduction of nerve area in the rapsyn +/- group when compared 
to the +/+ group. This should be a consideration for future study to confirm there was no NMJ 
impairment. 
Importantly, my experiments were limited by the number of available heterozygous agrin and 
rapsyn animals. A future study could be improved by increasing the sample size. This would 
involve performing a power analysis on the pilot data to determine the sample size required 
for each parameter to reach significance. Where possible, every attempt was made to reduce 
the effect of confounding factors during experimentation and data analysis. Heterozygous 
rapsyn and agrin mice numbers were limited by number of animals obtained from A/Prof. 
Peter Noakes laboratory at The University of Queensland (UQ). Where possible littermate 
animals were used for the control groups. However, control and treatment groups contained 
animals from different litters. Ideally identical housing conditions should be kept for all 
genotypes and treatment groups. However, some of the wild-type mice had been aged in the 
Bosch animal facility at the University of Sydney whilst all the heterozygous mice were aged in 
the Herston Facility at UQ. A general problem with aging studies is that aged animals tend to 
reveal larger animal-to-animal variability. The old mice also displayed greater endplate-to 
endplate variability when compared to younger animals (Tse et al., 2014). 
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This study gives evidence that indicates that reduced gene dosage for rapsyn and agrin 
expression may not result in premature reveal age-associated impairments, further study on 
the ageing NMJ under conditions of low agrin or rapsyn expression should be undertaken. 
Perhaps analysis of the NMJ at later age points would show impairments. Functional analysis 
using electrophysiological techniques could also be used to determine if the agrin/MuSK 
system influences robust NMJ function in old age. Also, it would be ideal to quantitatively 
determine levels of expression of agrin, MuSK and rapsyn expression in aged heterozygous 
animals and mice overexpressing these components. This might be done by use of 
immunoblotting and PCR based quantitation techniques. In future studies, a study comparing 
reduced gene dosage of major proteins of the MuSK system in both young and a range of age 
groups should be considered. 
 
 
 
6.1.3 MuSK Overexpression 
Following the experiments on agrin and rapsyn heterozygous mice, I tested the idea that 
elevated MuSK expression might delay or prevent age associated changes at the NMJ. NMJs of 
25 month old mice, expressing MuSK-GFP for 12 weeks, exhibited similar structural 
characteristics to contralateral controls (those not expressing MuSK-GFP). Previously, 
transgenic elevation of MuSK levels have been shown to delay denervation of endplates and 
improve motor function in ALS mice (Perez-Garcia & Burden, 2012). Thus elevated expression 
of MuSK in wild type mice might be expected to ameliorate age-associated changes to the 
NMJ. Distinct MuSK-EGFP fluorescence confirmed the elevated expression and appropriate 
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targeting to the endplate.  A possible explanation for these results could be the age-associated 
impairment of another pathway, which elevated MuSK levels cannot compensate for. Perhaps 
the earlier discussed laminin-integrin (alpha-7) pathway and laminin-dystroglycan Ach receptor 
signalling pathways are impaired in aged animals and over-expression cannot compensate for 
this loss. In fact, induction with agrin alone in myotubes is not sufficient to promote integrin 
colocalisation with AChR clustering and their subsequent aggregation into clusters. Src family 
kinases have also been implicated in the stability of AChR clustering and mice deficient in these 
proteins develop a phenotype of impaired neuromotor function. This indicates the 
involvement of other pathways involved in NMJ development or impairment {Smith, 2001}. 
The MuSK system is not the only pathway that is involved in development and maintenance of 
the NMJ. For example Wnt signalling, from the muscle itself and various regulatory proteins 
and neurotrophic factors, such as the glial cell line derived neurotrophic factor (GDNF) have 
already been described in the literature (Henriquez et al., 2008; Wu et al., 2010). The use of 
elderly mice posed an additional problem that several mice died of natural causes or had to be 
euthanased before they reached the age required for experiments. This was particularly the 
case for the experiments involving elevated MuSK expression. Therefore, the MuSK-GFP 
experiments only contained a small sample size. It is possible that statistical significance might 
have been reached with a larger sample size. Another problem I encountered was the 
expression and/or stability of MuSK-EGFP expression in aging mice after intramuscular 
injection of adeno-associated virus (AAV) vector. Some animals did not appear to take up the 
transgene, with no fibres expressing MuSK-GFP. Previous studies reported that  AAV gene 
transduction into mdx mice had lower transduction efficiency when applied to 9 month 
animals as compared with animals less than 7 weeks of age (Liu et al., 2005). Considering the 
animals used in my experiment were 25 months old at the time of analysis, the potential 
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effects of elevated MuSK expression may be greatly compromised. Other methods of 
overexpression should be considered. Several studies have shown successful methods of 
transgenic protein overexpression. {Acuna, 2016} cloned cDNA into a plasmid of which the 
construct was used for zygote microinjection. Transgenic mice were bred with c57BL6/J mice 
to produce wildtype and transgenic mice. The offspring was then screened for the presence of 
the transgene. {Deng, 2011} overexpressed miR-133a in skeletal muscle. A genomic fragment 
containing the miR-133a gene was amplified by PCR. The DNA fragment was then cloned into a 
vector plasmid and the construct was injected into the pronuclei of embryos and implanted 
into pseudo-pregnant females. A pilot study comparing the effectiveness of gene 
overexpression in aged animals should be considered.  
Study of additional parameters may further our understanding of the NMJ. Analysis of sites of 
neurotransmitter release, such as active zone proteins like bassoon, could provide insight into 
the pre-synaptic regions in aged animals. Better unbiased sampling for endplate density 
(including all microscopic fields whether an endplate is present or not), might yield more 
reliable assessment of any potential loss of NMJs with age. Functional data using 
electrophysiological techniques may reveal a change in function between treatment groups. 
This is required before dismissing the possibility of any differences between treatment groups. 
 
 
 
6.1.4 L25 line 
In Chapter 5 I studied the NMJs of paralysed L25 transgenic mice as a first of test whether 
degeneration of the axons of lower motor neurons might be part of the motor pathology. In 
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contradiction of this hypothesis I found no evidence that axons of lower motor neurons, 
including their NMJs, might contribute to muscle paralysis/weakness as observed in these 
mice. NMJs from six paralysed animals were analysed for the AChR area, nerve area, and 
overlap of nerve over AChR and AChR area fragmentation. Overall, this study showed that the 
parameters for NMJ structure were not altered in that affected L25 mice at their paralysis 
endpoint, when compared to wild type control mice. No statistical significance was observed 
between control and treatment groups for any parameter. Two animals from a paired group 
revealed a mean nerve area much lower than the other groups. This cannot be determined as 
due to a poor staining protocol on the day of the experiment because sections of mice from 
the control group were stained during the same staining run and revealed the expected 
average normal nerve terminal area. The reason for the small nerve terminals in these two 
mice is not certain. This could be due to the endpoint of these mice being determined as when 
their motor symptoms were more severe than the other pairs. However, the outlier, affected 
animal P7.3mREP, did not appear show as many motor symptom defects at the endpoint as 
the other affected animals included in the study (table 5.1). This rules out the consideration 
that the endpoint was determined further along than other animals in the study.  
Concerning the L25 transgenic mice one difficulty was in specifying a consistent endpoint when 
the animals were killed for analysis (Kichkin, E, Honours thesis 2014). The endpoint criteria had 
to be a balance between the welfare of the animal and the appearance of the end stage motor 
phenotype. The pre-determined endpoint criteria was that the mouse be killed when it lost 
15% of its peak body weight or failed to right itself within 10 seconds after being put on its 
back. Not all animals that fulfilled these criteria had developed severe motor deficits such as 
spastic paralysis. The inclusion of non-paralysed animals in the dataset may have prevented 
statistical significance between affected and non-affected groups.  
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The results from the L25 study suggest that nerve terminals (and presumably the lower motor 
neurons), are not involved in affected mice.  The symptoms of hind limb spasticity, body 
tremor and paralysis presumably lies further up the motor control pathway. Functional studies 
should be performed to confirm that no difference exists between treatment groups. Future 
research should be directed at the upper motor neurons and spinal cord axon tracts to 
determine whether the cause of the motor neuron disease (MND) - like symptoms is from the 
loss of premotor neuron populations. Further research into the gene disrupted by the L25 
transgene insert should provide insight into the cause of the phenotype. It is possible that this 
may be a currently unknown cause for some subsets of MND in humans.  
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